<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Probiotics for vulvovaginal candidiasis in non‐pregnant women - Xie, HY - 2017 | Cochrane Library</title> <meta content="Probiotics for vulvovaginal candidiasis in non‐pregnant women - Xie, HY - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010496.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Probiotics for vulvovaginal candidiasis in non‐pregnant women - Xie, HY - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010496.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010496.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Probiotics for vulvovaginal candidiasis in non‐pregnant women" name="citation_title"/> <meta content="Huan Yu Xie" name="citation_author"/> <meta content="People's Hospital of Deyang City" name="citation_author_institution"/> <meta content="Dan Feng" name="citation_author"/> <meta content="Cheng du Women ＆ Children's Central Hospital" name="citation_author_institution"/> <meta content="Dong Mei Wei" name="citation_author"/> <meta content="West China Second University Hospital, West China Women's and Children's Hospital" name="citation_author_institution"/> <meta content="Ling Mei" name="citation_author"/> <meta content="West China Second University Hospital, West China Women's and Children's Hospital" name="citation_author_institution"/> <meta content="Hui Chen" name="citation_author"/> <meta content="West China Second University Hospital, West China Women's and Children's Hospital" name="citation_author_institution"/> <meta content="Xun Wang" name="citation_author"/> <meta content="West China Second University Hospital, West China Women's and Children's Hospital" name="citation_author_institution"/> <meta content="Fang Fang" name="citation_author"/> <meta content="West China Second University Hospital, Sichuan University" name="citation_author_institution"/> <meta content="ffmn59@163.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD010496.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/11/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010496.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010496.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010496.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Intravaginal; Antifungal Agents [administration &amp; dosage]; Candidiasis, Vulvovaginal [prevention &amp; control, *therapy]; Clotrimazole [administration &amp; dosage]; Fluconazole [administration &amp; dosage]; Imidazoles [administration &amp; dosage]; Miconazole [administration &amp; dosage]; Probiotics [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010496.pub2&amp;doi=10.1002/14651858.CD010496.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="23LRTUA6";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010496\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010496\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","th","ja","fr","zh_HANS","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010496.pub2",title:"Probiotics for vulvovaginal candidiasis in non\\u2010pregnant women",firstPublishedDate:"Nov 23, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane STI Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=23LRTUA6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010496.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010496.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010496.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010496.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010496.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010496.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010496.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010496.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010496.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010496.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>16231 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010496.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-sec-0121"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-sec-0052"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-sec-0053"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-sec-0077"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-sec-0115"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/appendices#CD010496-sec-0126"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/table_n/CD010496StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/table_n/CD010496StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Probiotics for vulvovaginal candidiasis in non‐pregnant women</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#CD010496-cr-0002">Huan Yu Xie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#CD010496-cr-0003">Dan Feng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#CD010496-cr-0004">Dong Mei Wei</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#CD010496-cr-0005">Ling Mei</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#CD010496-cr-0006">Hui Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#CD010496-cr-0007">Xun Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information#CD010496-cr-0008"><i class="icon corresponding-author fa fa-envelope"></i>Fang Fang</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information/en#CD010496-sec-0137">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 November 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010496.pub2">https://doi.org/10.1002/14651858.CD010496.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010496-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010496-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010496-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010496-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010496-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD010496-abs-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010496-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010496-abs-0001" lang="en"> <section id="CD010496-sec-0001"> <h3 class="title" id="CD010496-sec-0001">Background</h3> <p>Vulvovaginal candidiasis (VVC) is estimated to be the second most common form of infection after bacterial vaginosis. The ability of probiotics in maintaining and recovering the normal vaginal microbiota, and their potential ability to resist <i>Candidas</i> give rise to the concept of using probiotics for the treatment of VVC. </p> </section> <section id="CD010496-sec-0002"> <h3 class="title" id="CD010496-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of probiotics for the treatment of vulvovaginal candidiasis in non‐pregnant women. </p> </section> <section id="CD010496-sec-0003"> <h3 class="title" id="CD010496-sec-0003">Search methods</h3> <p>We searched the following databases to October 2017: Sexually Transmitted Infections Cochrane Review Group's Specialized Register, CENTRAL, MEDLINE, Embase and eight other databases. We searched in following international resources: World Health Organization International Clinical Trials Registry Platform, ClinicalTrials.gov, Web of Science and OpenGrey. We checked specialty journals, reference lists of published articles and conference proceedings. We collected information from pharmaceutical companies and experts in the field. </p> </section> <section id="CD010496-sec-0004"> <h3 class="title" id="CD010496-sec-0004">Selection criteria</h3> <p>Randomized controlled trials (RCT) using probiotics, alone or as adjuvants to conventional antifungal drugs, to treat VVC in non‐pregnant women. Trials recruiting women with recurrent VVC, coinfection with other vulvovaginal infections, diabetes mellitus, immunosuppressive disorders or taking immunosuppressant medication were ineligible for inclusion. Probiotics were included if they were made from single or multiple species and in any preparation type/dosage/route of administration. </p> </section> <section id="CD010496-sec-0005"> <h3 class="title" id="CD010496-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trials for eligibility and quality and extracted data. We resolved any disagreements through consensus. The quality of the evidence was assessed using the GRADE approach. </p> </section> <section id="CD010496-sec-0006"> <h3 class="title" id="CD010496-sec-0006">Main results</h3> <p>Ten RCTs (1656 participants) met our inclusion criteria, and pharmaceutical industry funded none of these trials. All trials used probiotics as adjuvant therapy to antifungal drugs. Probiotics increased the rate of short‐term clinical cure (risk ratio (RR) 1.14, 95% confidence interval (CI) 1.05 to 1.24, 695 participants, 5 studies, low quality evidence) and mycological cure (RR 1.06, 95% CI 1.02 to 1.10, 969 participants, 7 studies, low quality evidence) and decreased relapse rate at one month (RR 0.34, 95% CI 0.17 to 0.68, 388 participants, 3 studies, very low quality evidence). However, this effect did not translate into a higher frequency of long‐term clinical cure (one month after treatment: RR 1.07, 95% CI 0.86 to 1.33, 172 participants, 1 study, very low quality evidence; three months after treatment: RR 1.30, 95% CI 1.00 to 1.70, 172 participants, one study, very low quality evidence) or mycological cure (one month after treatment: RR 1.26, 95% CI 0.93 to 1.71, 627 participants, 3 studies, very low quality evidence; three months after treatment: RR 1.16, 95% CI 1.00 to 1.35, 172 participants, one study, very low quality evidence). Probiotics use did not increase the frequency of serious (RR 0.80, 95% CI 0.22 to 2.94; 440 participants, 2 studies, low quality evidence). We found no eligible RCTs for outcomes as time to first relapse, need for additional treatment at the end of therapy, patient satisfaction and cost effectiveness. </p> </section> <section id="CD010496-sec-0007"> <h3 class="title" id="CD010496-sec-0007">Authors' conclusions</h3> <p>Low and very low quality evidence shows that, compared with conventional treatment, the use of probiotics as an adjuvant therapy could increases the rate of short‐term clinical and mycological cure and decrease the relapse rate at one month but this did not translate into a higher frequency of long‐term clinical or mycological cure. Probiotics use does not seem to increase the frequency of serious or non‐serious adverse events. There is a need for well‐designed RCTs with standardized methodologies, longer follow‐up and larger sample size. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010496-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010496-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010496-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010496-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010496-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010496-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010496-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010496-abs-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD010496-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010496-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010496-abs-0005" lang="en"> <h3>Probiotics for vulvovaginal candidiasis in non‐pregnant women</h3> <p><b>Question</b> </p> <p>In this Cochrane Review, we assessed the effect and safety of probiotics for the treatment of vulvovaginal candidiasis (VVC) in non‐pregnant women compared with conventional antifungal drugs, or probiotics used to change the effects of conventional antifungal drugs. </p> <p><b>Background</b> </p> <p>The condition of VVC occurs because of an imbalance in the normal vaginal microorganism habitat (microbiota). It is characterized by a decrease of a type of bacteria called lactobacilli and a concomitant overgrowth of a fungus called <i>Candida</i> . Although treatments for VVC by conventional antifungal drugs are quite effective at providing clinical cure (no apparent vaginal symptoms), there is an increasing in resistance to the drugs and recurrence of VVC. Conventional antifungal drugs can also cause many side effects. Probiotics are microorganisms that are believed to provide health benefits when consumed. The ability of probiotics in maintaining and recovering the normal vaginal microbiota, and their potential ability to resist <i>Candidas</i> gives rise to the concept of using probiotics for the treatment of VVC. We wanted to find out whether using probiotics could be useful in treating VVC in non‐pregnant women without high risk or side effects. </p> <p><b>Study characteristics</b> </p> <p>We searched evidence up to October 2017 and included 10 clinical trials with 1656 participants. The trials lasted between three months and five years. All trials used at least one laboratory method for diagnosis. Four trials compared vaginal suppository (solid medicine inserted directly into the vagina) or tablet of clotrimazole (antifungal medicine) plus vaginal capsules of probiotics with vaginal suppository or tablet of clotrimazole alone. Three trials compared vaginal suppository of miconazole (antifungal medicine) plus vaginal capsules of probiotics with vaginal suppository of miconazole alone. Two trials compared oral fluconazole (antifungal medicine) plus oral capsules of probiotics with oral fluconazole plus oral capsules of placebo (pretend treatment). One trial compared oral fluconazole and vaginal fenticonazole (antifungal medicines) with oral fluconazole plus vaginal fenticonazole plus probiotic. </p> <p><b>Key results</b> </p> <p>Compared with conventional antifungal drugs used alone, probiotics as adjuvant therapy could enhance their effect in improving the rate of short‐term (within five to 10 days) clinical cure, short‐term mycological cure (no abnormal laboratory results) and relapse at one month (recurrence of problems), but does not seem to influence the rate of long‐term (within one to three months) clinical cure, long‐term mycological cure, serious and non‐serious side events. </p> <p>However, because of the low quality of evidence available, there is insufficient evidence for the use of probiotics as adjuvants to conventional antifungal medicines or used alone for the treatment of VVC in non‐pregnant women. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence was low or very low in this review, so we have very little confidence in the results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010496-sec-0121" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010496-sec-0121">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010496-sec-0169">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010496-sec-0121"></div> <h3 class="title" id="CD010496-sec-0122">Implications for practice</h3> <section id="CD010496-sec-0122"> <p>Low and very low quality evidence shows that, compared with conventional treatment, probiotics as adjuvant therapy may increase the rate of short‐term clinical and mycological cure and decrease relapse rate at one month but this did not translate into a higher frequency of long‐term clinical or mycological cure. Probiotic use may not increase the frequency of serious or non‐serious adverse events. The benefits and harms of probiotics for vulvovaginal candidiasis in non‐pregnant women should be regarded with caution due to the risk of bias, imprecision and inconsistency for many of the outcomes we assessed in this Cochrane Review. </p> </section> <h3 class="title" id="CD010496-sec-0123">Implications for research</h3> <section id="CD010496-sec-0123"> <p>Because the quality of available evidence is low, there is a need for well‐designed randomized controlled trials with adequate allocation concealment and blinding of participants, personnel and outcome assessment; longer follow‐up and larger sample size; and when probiotics are designed to be used as adjuvants to conventional antifungal drugs, placebo should be used in the control group to avoid any possible bias from the judgment of symptoms and signs by participants. The possible influence from different route of administration, probiotics species, candidal strains and age group of participants should be followed with interest. Sustained attention should be paid to the adverse events to determine the safety of probiotics. More range of racial, cultural and social groups are needed. Any future high‐quality trials should include the outcomes evaluated in this review as much as possible. Other types of comparisons are also needed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010496-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010496-sec-0043"></div> <div class="table" id="CD010496-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Probiotics used as adjuvants to conventional antifungal drugs compared with conventional antifungal drugs for the treatment of vulvovaginal candidiasis in non‐pregnant women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Probiotics used as adjuvants to conventional antifungal drugs compared with conventional antifungal drugs for the treatment of vulvovaginal candidiasis in non‐pregnant women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Patient or population:</b> non‐pregnant women with vulvovaginal candidiasis </p> <p><b>Settings:</b> outpatient clinics in Brazil, Bulgaria, Iran and China </p> <p><b>Intervention:</b> probiotics used as adjuvants to conventional antifungal drugs </p> <p><b>Comparison:</b> conventional antifungal drugs </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="2" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Conventional antifungal drugs</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Probiotics used as adjuvants to conventional antifungal drugs</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Clinical cure rate (short‐term)</b> </p> <p>follow‐up: 5‐10 days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.14</b> (1.05 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>695<br/> (5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>721 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>822 per 1000</b> <br/> (757 to 894) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Clinical cure rate (long‐term)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>1 month after treatment</b> </p> <p>follow‐up: 1 month</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.07</b> (0.86 to 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>172<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>635 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>679 per 1000</b> <br/> (546 to 845) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>3 months after treatment</b> </p> <p>follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.30</b> (1.00 to 1.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>172<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>494 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>642 per 1000</b> <br/> (494 to 840) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Mycological cure rate (short‐term)</b> </p> <p>follow‐up: 5‐10 days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.06</b> (1.02 to 1.10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>969<br/> (7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See <sup>3</sup> in footnotes. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>880 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>933 per 1000</b> <br/> (898 to 968) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mycological cure rate (long‐term)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>1 month after treatment</b> </p> <p>follow‐up: 28‐30 days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> (0.93 to 1.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>627<br/> (3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See <sup>5</sup> in footnotes. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>706 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>890 per 1000</b> <br/> (657 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>3 months after treatment</b> </p> <p>follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b> (1.00 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>172<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>741 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>860 per 1000</b> <br/> (741 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Relapse rate</b> </p> <p>follow‐up: 30‐37 days after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.34</b> (0.17 to 0.68) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>388<br/> (3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>145 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> <br/> (25 to 99) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Rate of serious adverse events</b> </p> <p>follow‐up: 5‐90 days after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.80</b> (0.22 to 2.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>440<br/> (2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (5 to 68) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels due to very serious risk of bias: the included studies had a high or unclear risk of bias in at least one key domain i.e. random sequence generation, allocation concealment or blinding. </p> <p><sup>2</sup>Downgraded one level due to serious imprecision: the 95% CI were wide and included null effects. </p> <p><sup>3</sup>A sensitivity analysis that excluded studies with high risk of bias and included only one study showed that the rate of short‐term mycological cure was changed to no significantly difference between two arms. For the heterogeneity and difference in results, we think the reasons may be associated with the small sample of included study, high risk of bias of studies that were excluded for sensitivity analysis. </p> <p><sup>4</sup>Downgraded one level due to inconsistency: there was a substantial heterogeneity between studies. </p> <p><sup>5</sup>There was heterogeneity that may be attributable to differences in route of the administration of probiotics, we undertook a subgroup analysis, the results showed no statistically significant difference between two arms in either subgroup. </p> <p><sup>6</sup>Downgraded one level due to serious imprecision: small sample size and few events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010496-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010496-sec-0044">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010496-sec-0146">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010496-sec-0044"></div> <section id="CD010496-sec-0045"> <h3 class="title" id="CD010496-sec-0045">Description of the condition</h3> <section id="CD010496-sec-0046"> <h4 class="title">Epidemiology</h4> <p>Vaginitis is one of the most common reasons for women to seek medical assistance from obstetrician and gynecologists (<a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). Vulvovaginal candidiasis (VVC) is estimated to be the second most common form of vaginal infection after bacterial vaginosis (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0052" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009a</a>). Data about the incidence of VVC are limited and incomplete, since it is not a reportable disease and is often diagnosed without mycological confirmatory (fungi identified) tests and treated with non‐prescription drugs (<a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0056" title="NyirjesyP , SobelJD . Candidal vulvovaginitis. Obstetrics and Gynecology Clinics of North America2003;30(4):671‐84. ">Nyirjesy 2003</a>). Misdiagnosis is common, and it has been shown that about two‐thirds of all non‐prescription drugs for VVC are used without the disease, and that women who overused non‐prescription antifungal drugs, may increase the risk of resistance to antifungal treatments (<a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). </p> <p>Approximately 70% to 75% of women experience at least one episode of VVC in their lives (<a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). Age appears to be an important factor in the overall incidence of VVC because episodes occur mostly during childbearing years and rarely in premenarchal and postmenopausal years (<a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). Approximately 40% to 45% of women will experience two or more episodes of VVC in one year (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). One epidemiological study indicated that the frequency of the first diagnosis of VVC increased rapidly after 17 years of age. By the age of 25 years, 54.7% of female college students experienced at least one episode of physician‐diagnosed VVC (<a href="./references#CD010496-bbs2-0041" title="GeigerAM , FoxmanB , GillespieBW . The epidemiology of vulvovaginal candidiasis among university students. American Journal of Public Health1995;85(8 Pt 1):1146‐8. ">Geiger 1995</a>). Recurrent VVC (RVVC) is defined as four or more episodes in one year, and affects 5% to 8% of adult women (<a href="./references#CD010496-bbs2-0039" title="FoxmanB , MarshJV , GillespieB , SobelJD . Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. Journal of Womens Health1998;7:1167‐74. ">Foxman 1998</a>; <a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0037" title="FalagasME , BetsiGI , AthanasiouS . Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy2006;58(2):266‐72. ">Falagas 2006</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). It is reported that the incidence of VVC almost doubled from 1980 to 1990, based on the number of prescriptions written to treat VVC during that period (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). The annual combined cost of health care and lost productivity due to VVC in the US was estimated to be USD1.8 billion, and is projected to reach USD3.1 billion by 2014 (<a href="./references#CD010496-bbs2-0040" title="FoxmanB , BarlowR , D'ArcyH , GillespieB , SobelJD . Candida vaginitis: self‐reported incidence and associated costs. Sexually Transmitted Diseases.2000;27:230‐5. ">Foxman 2000</a>). </p> </section> <section id="CD010496-sec-0047"> <h4 class="title">Pathology</h4> <p>The vaginal microenvironment is a complex microecological system, and <i>Lactobacillus</i> is the most commonly dominant flora (the aggregate of bacteria, fungi or other microorganisms) in the vaginal microecological system (<a href="./references#CD010496-bbs2-0063" title="Redondo‐LopezV , CookRL , SobelJD . Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Reviews of Infectious Diseases1990;12(5):856‐72. ">Redondo‐Lopez 1990</a>; <a href="./references#CD010496-bbs2-0049" title="KledanoffSJ , HillierSL , EschenbachDA , WaltersdorphAM . Control of the microbial flora of the vagina by H2O2 generating lactobacilli. Journal of Infectious Diseases1991;164(1):94‐100. ">Kledanoff 1991</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). In normal conditions, vaginal lactobacilli produce lactic acid, thus acidifying the healthy vagina to a low pH level (4.5 or less), which could inhibit the overgrowth of other pathogenic bacteria or <i>Candida</i> (<a href="./references#CD010496-bbs2-0063" title="Redondo‐LopezV , CookRL , SobelJD . Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Reviews of Infectious Diseases1990;12(5):856‐72. ">Redondo‐Lopez 1990</a>; <a href="./references#CD010496-bbs2-0049" title="KledanoffSJ , HillierSL , EschenbachDA , WaltersdorphAM . Control of the microbial flora of the vagina by H2O2 generating lactobacilli. Journal of Infectious Diseases1991;164(1):94‐100. ">Kledanoff 1991</a>). Many species of <i>Lactobacillus</i> also produce other substances, such as hydrogen peroxide and bacteriocin, which further prevent the overgrowth of the pathogenic microbes (<a href="./references#CD010496-bbs2-0063" title="Redondo‐LopezV , CookRL , SobelJD . Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Reviews of Infectious Diseases1990;12(5):856‐72. ">Redondo‐Lopez 1990</a>; <a href="./references#CD010496-bbs2-0049" title="KledanoffSJ , HillierSL , EschenbachDA , WaltersdorphAM . Control of the microbial flora of the vagina by H2O2 generating lactobacilli. Journal of Infectious Diseases1991;164(1):94‐100. ">Kledanoff 1991</a>; <a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0047" title="JeavonsHS . Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus . Journal of Obstetric, Gynecologic, and Neonatal Nursing2003;32(3):287‐96. ">Jeavons 2003</a>; <a href="./references#CD010496-bbs2-0056" title="NyirjesyP , SobelJD . Candidal vulvovaginitis. Obstetrics and Gynecology Clinics of North America2003;30(4):671‐84. ">Nyirjesy 2003</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). </p> <p>The condition of VVC occurs as a result of an imbalance in the normal vaginal microbiota (the group of microbe) and is characterized by a decrease or depletion of the lactobacilli species and a concomitant overgrowth of <i>Candida</i> species, epidemiological research has shown that <i>Candida</i> organisms can be found in approximate 20% of asymptomatic healthy women (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). <i>Candida</i> organisms gain access to the vaginal lumen and discharge mainly from the adjacent perianal area, effective anti‐<i>Candida</i> defense in the microenvironment of the vagina allows candidal microbes to persist as an avirulent commensal (<a href="./references#CD010496-bbs2-0031" title="BertholfME , StaffordMJ . Colonization of Candida albicans in vagina, rectum, and mouth. Journal of Family Practice1983;16:919‐24. ">Bertholf 1983</a>; <a href="./references#CD010496-bbs2-0030" title="BeigiRH , MeynLA , MooreDM , KrohnMA , HillierSL . Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstetrics and Gynecology2004;104:926‐30. ">Beigi 2004</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). There are two potential elements during the development of symptomatic VVC: the first is the <i>Candida</i> species' vaginal colonization, adhesion, invasion and growth, and the second is the transformation from the asymptomatic to the symptomatic phase (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). <i>Candida</i> enters the vagina through different sources, including local spread from the perineum (the area in front of the anus extending to the fourchette of the vulva) and gastrointestinal tract, digital introduction and unclean sexual activity (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). Estrogen is believed to be crucial in the maintenance of colonization (<a href="./references#CD010496-bbs2-0045" title="HillierSL ,  LauRJ . Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clinical Infectious Diseases1997;25(Suppl 2):S123‐6. ">Hillier 1997</a>). The penetrative ability of hyphae enhances the colonization by the adherence to vaginal epithelial cells (<a href="./references#CD010496-bbs2-0063" title="Redondo‐LopezV , CookRL , SobelJD . Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Reviews of Infectious Diseases1990;12(5):856‐72. ">Redondo‐Lopez 1990</a>; <a href="./references#CD010496-bbs2-0074" title="RossRA , LeeML , OnderdonkAB . Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstetrics and Gynecology1995;86(6):925‐30. ">Ross 1995</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). One study indicated that <i>Candida albicans</i> adheres in significantly higher numbers to vaginal epithelial cells than non‐albicans <i>Candida</i> species (<a href="./references#CD010496-bbs2-0083" title="SollDR , GalaskR , IsleyS , RaoTV , StoneD , HicksJ , et al. Switching of Candida albicans during successive episodes of recurrent vaginitis. Journal of Clinical Microbiology1989;27(4):681‐90. ">Soll 1989</a>). The <i>Candida</i> strains isolated from the vaginas of women with VVC are mainly <i>Candida albicans</i> , while the rest (range 5% to 15%) are non‐albicans <i>Candida</i> species. <i>Candida glabrata</i> is considered the most common of non‐albicans <i>Candida</i> species (<a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). However, vulvovaginitis induced by non‐albicans <i>Candida</i> cannot be distinguished clinically from that caused by <i>Candida albicans</i> . RVVC is often caused by non‐albicans <i>Candida</i>, which are frequently more resistant to conventional antifungal treatment (<a href="./references#CD010496-bbs2-0084" title="SpinilloA , NicolaS , ColonnaL , MarangoniE , CavannaC , MicheloneG . Frequency and significance of drug resistance in vulvovaginal candidiasis. Gynecologic and Obstetric Investigation1994;38(2):130‐3. ">Spinillo 1994</a>; <a href="./references#CD010496-bbs2-0074" title="RossRA , LeeML , OnderdonkAB . Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstetrics and Gynecology1995;86(6):925‐30. ">Ross 1995</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). Some studies have shown that the widespread and long‐term use of antifungal drugs such as azoles, particularly fluconazole, may lead to a pathogen shift and increase the incidence of the non‐albicans <i>Candida</i> such as <i>Candida glabrata</i> , and the extensive use of azoles may effectively suppress <i>Candida albicans</i> but facilitate the overgrowth of non‐albicans <i>Candida</i> (<a href="./references#CD010496-bbs2-0076" title="SanglardD ,  OddsFC . Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infectious Diseases2002;2(2):73‐85. ">Sanglard 2002</a>; <a href="./references#CD010496-bbs2-0043" title="HettiarachchiN , AshbeeHR , WilsonJD . Prevalence and management of non‐albicans vaginal candidiasis. Sexually Transmitted Infections2010;86(2):99‐100. ">Hettiarachchi 2010</a>; <a href="./references#CD010496-bbs2-0051" title="Mahmoudi RadM , ZafarghandiS , AbbasabadiB , TavallaeeM . The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;155(2):199‐203. ">Mahmoudi 2011</a>). Depressed or reduced protective local immunoregulatory mechanisms, cytokine (any of several non‐antibody proteins, released by a cell population on contact with a specific antigen and act as intercellular mediators, as in the generation of an immune response) elaboration and certain genetic polymorphisms may result in increased susceptibility to RVVC (<a href="./references#CD010496-bbs2-0042" title="GiraldoPC , BabulaO , GonçalvesAK , LinharesIM , AmaralRL , LedgerWJ , et al. Mannose‐binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstetrics and Gynecology2007;109(5):1123‐8. ">Giraldo 2007</a>). </p> <p>The overuse of antibiotics; pregnancy; diabetes mellitus; immunosuppression; frequent and unclean sexual activity; use of oral contraceptives, diaphragms, spermicide and intrauterine devices; and vaginal douching are considered important risk factors for the development of VVC and RVVC (<a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0056" title="NyirjesyP , SobelJD . Candidal vulvovaginitis. Obstetrics and Gynecology Clinics of North America2003;30(4):671‐84. ">Nyirjesy 2003</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). </p> <p>VVC can be classified as uncomplicated VVC and complicated VVC (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). </p> <p> <ul id="CD010496-list-0001"> <li> <p>Uncomplicated VVC is defined by:</p> <ul id="CD010496-list-0002"> <li> <p>sporadic or infrequent VVC, or</p> </li> <li> <p>mild‐to‐moderate VVC, or</p> </li> <li> <p>likely to be <i>Candida albicans</i> infection, or </p> </li> <li> <p>non‐immunocompromised host.</p> </li> </ul> </li> <li> <p>Complicated VVC is defined by:</p> <ul id="CD010496-list-0003"> <li> <p>four or more episodes of candidiasis per year (RVVC), or</p> </li> <li> <p>severe symptoms or findings (severe VVC), or</p> </li> <li> <p>non‐albicans <i>Candida</i> infection, or </p> </li> <li> <p>abnormal host (e.g. uncontrolled diabetes, debilitation or immunosuppression).</p> </li> </ul> </li> </ul> </p> </section> <section id="CD010496-sec-0048"> <h4 class="title">Diagnosis</h4> <p>A combination of clinical signs and symptoms, microscopic examination, vaginal culture, or a combination of these is used to diagnose VVC; although acute pruritus and vaginal discharge are the common clinical symptoms of VVC, neither of them is specific (<a href="./references#CD010496-bbs2-0028" title="AndersonMR , KlinkK , CohrssenA . Evaluation of vaginal complaints. JAMA2004;291:1368. ">Anderson 2004</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). The typical vaginal discharge has been described as 'cottage‐cheese‐like,' and in practice it could vary from watery to thick (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). Women with VVC may also complain of irritation, soreness, vulvar burning or dyspareunia. Occasionally, VVC can cause external dysuria (difficult or painful urination) by the burning that occurs when urine hits the inflamed vulvar tissues (<a href="./references#CD010496-bbs2-0036" title="EckertLO ,  HawesSE ,  StevensCE ,  KoutskyLA ,  EschenbachDA ,  HolmesKK . Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstetrics and Gynecology1998;92:757‐65. ">Eckert 1998</a>). If there is an odor, it is generally insignificant and inoffensive (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). Clinical symptoms may recur or exacerbate in the week before menstruation (<a href="./references#CD010496-bbs2-0078" title="SchaafVM , Perez‐StableEJ , BorchardtK . The limited value of symptoms and signs in the diagnosis of vaginal infections. Archives of Internal Medicine1990;150:1929. ">Schaaf 1990</a>; <a href="./references#CD010496-bbs2-0028" title="AndersonMR , KlinkK , CohrssenA . Evaluation of vaginal complaints. JAMA2004;291:1368. ">Anderson 2004</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). On vulvar examination, women may exhibit erythema (redness of the skin caused by dilation and congestion of the capillaries, often a sign of inflammation or infection), swelling, fissures, or excoriations of the labia and vulva, and vaginal signs of erythema or an adherent curd‐like vaginal discharge may be found (<a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0056" title="NyirjesyP , SobelJD . Candidal vulvovaginitis. Obstetrics and Gynecology Clinics of North America2003;30(4):671‐84. ">Nyirjesy 2003</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). </p> <p>Most women with symptoms of VVC can be easily diagnosed when:</p> <p> <ul id="CD010496-list-0004"> <li> <p>saline and 10% potassium hydroxide microscopy examination or Gram stain (63.2% to 65% sensitivity, 97.2% to 100% specificity (<a href="./references#CD010496-bbs2-0058" title="OmarAA . Gram stain versus culture in the diagnosis of vulvovaginal candidiasis. Eastern Mediterranean Health Journal2001;7(6):925‐34. ">Omar 2001</a>; <a href="./references#CD010496-bbs2-0046" title="IlkitM , GuzelAB . The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Critical Reviews in Microbiology2011;37(3):250‐61. ">Ilkit 2011</a>)) of vaginal discharge demonstrates <i>Candida</i> species, hyphae or pseudohyphae; or </p> </li> <li> <p>a vaginal culture test yields a <i>Candida</i> species (<a href="./references#CD010496-bbs2-0081" title="SobelJD , FaroS , ForceRW , FoxmanB , LedgerWJ , NyirjesyPR , et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology1998;178(2):203‐11. ">Sobel 1998</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). </p> </li> </ul> </p> <p>Because <i>Candida</i> vaginitis is associated with a normal vaginal pH (less than 4.5), pH testing is not useful for diagnosis, but the finding of a normal pH helps to exclude bacterial vaginosis, trichomoniasis, atrophic vaginitis or some type of mixed infection (<a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). </p> <p>The 10% potassium hydroxide microscopy examination (50% to 85% sensitivity) should be taken for all women with symptoms or signs of VVC, and women with a positive result should receive treatment (<a href="./references#CD010496-bbs2-0046" title="IlkitM , GuzelAB . The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Critical Reviews in Microbiology2011;37(3):250‐61. ">Ilkit 2011</a>; <a href="./references#CD010496-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>). The gold standard for diagnosis is still the growth of the infecting organism in fungal culture on Sabouraud dextrose agar (<a href="./references#CD010496-bbs2-0046" title="IlkitM , GuzelAB . The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Critical Reviews in Microbiology2011;37(3):250‐61. ">Ilkit 2011</a>). Up to 50% of women with culture‐positive symptomatic vulvovaginal candidiasis will have negative microscopy (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>), so, although routine cultures are not necessary if microscopy is positive, vaginal culture should be performed for women with a negative microscopy result and a normal pH and who are symptomatic (<a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). Vaginal culture is useful to identify the species of <i>Candida</i> (<a href="./references#CD010496-bbs2-0032" title="BieberEJ , SanfilippoJS , HorowitzIR . Clinical Gynecology. Philadelphia (PA): Churchill Livingstone, 2006. ">Bieber 2006</a>). For women with complicated VVC, vaginal culture can guide the choice of therapy regimen, since non‐albicans species tend to be resistant to the azole drugs (<a href="./references#CD010496-bbs2-0032" title="BieberEJ , SanfilippoJS , HorowitzIR . Clinical Gynecology. Philadelphia (PA): Churchill Livingstone, 2006. ">Bieber 2006</a>; <a href="./references#CD010496-bbs2-0057" title="NyirjesyP . Vulvovaginal candidiasis and bacterial vaginosis. Infectious Disease Clinics of North America2008;22(4):637‐52. ">Nyirjesy 2008</a>). <a href="#CD010496-tbl-0002">Table 1</a> lists species of <i>Candida</i> isolated from the lower genital tract in women with VVC. <i>Candida</i> identified by vaginal culture in the absence of symptoms or signs is not an indication for treatment, because many women harbor <i>Candida</i> species in the vagina. If the 10% potassium hydroxide examination is negative and vaginal culture cannot be performed, an empiric treatment may be considered for symptomatic women with any sign of VVC on examination (<a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). </p> <div class="table" id="CD010496-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Species of Candida isolated from lower genital tract in women with vulvovaginal candidiasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Species </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Response to azoles</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida albicans</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80‐90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensitive</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida glabrata</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5‐10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida krusei</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida lusitaniae</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida parapsilosis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida pseudotropicalis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida tropicalis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Source: <a href="./references#CD010496-bbs2-0032" title="BieberEJ , SanfilippoJS , HorowitzIR . Clinical Gynecology. Philadelphia (PA): Churchill Livingstone, 2006. ">Bieber 2006</a>. </p> </div> </div> <p>Although polymerase chain reaction (PCR) testing for <i>Candida</i> species is available, its usefulness is limited because it depends on obtaining PCR for the full spectrum of organisms that can cause VVC, with the associated costs (<a href="./references#CD010496-bbs2-0085" title="TramaJP , AdelsonME , RaphaelliI , StemmerSM , MordechaiE . Detection of Candida species in vaginal samples in a clinical laboratory setting. Infectious Diseases in Obstetrics and Gynecology2005;13(2):63‐7. ">Trama 2005</a>). </p> </section> </section> <section id="CD010496-sec-0049"> <h3 class="title" id="CD010496-sec-0049">Description of the intervention</h3> <p>The recommended treatments for uncomplicated VVC involve a short course of antifungal drugs (<a href="./references#CD010496-bbs2-0055" title="NurbhaiM , GrimshawJ , WatsonM , BondC , MollisonJ , LudbrookA . Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD002845.pub2] ">Nurbhai 2007</a>; <a href="./references#CD010496-bbs2-0060" title="PappasPG ,  KauffmanCA ,  AndesD ,  BenjaminDKJr ,  CalandraTF ,  EdwardsJEJr , et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases2009;48(5):503‐35. ">Pappas 2009</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). <a href="#CD010496-tbl-0003">Table 2</a> lists the Centers for Disease Control (CDC)‐recommended treatments for uncomplicated VVC (<a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). The oral and topical preparations have similar effects (<a href="./references#CD010496-bbs2-0060" title="PappasPG ,  KauffmanCA ,  AndesD ,  BenjaminDKJr ,  CalandraTF ,  EdwardsJEJr , et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases2009;48(5):503‐35. ">Pappas 2009</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>), and treatment with azole drugs results in relief of symptoms and negative cultures in 80% to 90% of women who complete therapy (<a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). The recommended treatments for complicated VVC involve an intensive, longer course of antifungals. <a href="#CD010496-tbl-0004">Table 3</a> lists the CDC‐recommended treatments for complicated VVC (<a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). </p> <div class="table" id="CD010496-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">CDC recommended treatments for uncomplicated vulvovaginal candidiasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Non‐prescription intravaginal agents</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Prescription intravaginal agents</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Butoconazole 2% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Clotrimazole 1% cream 5 g intravaginally for 7‐14 days</p> <p>OR</p> <p>Clotrimazole 2% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Miconazole 2% cream 5 g intravaginally for 7 days</p> <p>OR</p> <p>Miconazole 4% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Miconazole 100 mg vaginal suppository, 1 suppository for 7 days</p> <p>OR</p> <p>Miconazole 200 mg vaginal suppository, 1 suppository for 3 days</p> <p>OR</p> <p>Miconazole 1200 mg vaginal suppository, 1 suppository for 1 day</p> <p>OR</p> <p>Tioconazole 6.5% ointment 5 g intravaginally in a single application</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Butoconazole 2% cream (single dose bioadhesive product), 5 g intravaginally for 1 day </p> <p>OR</p> <p>Nystatin 100,000 unit vaginal tablet, 1 tablet for 14 days</p> <p>OR</p> <p>Terconazole 0.4% cream 5 g intravaginally for 7 days</p> <p>OR</p> <p>Terconazole 0.8% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Terconazole 80 mg vaginal suppository, 1 suppository for 3 days</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CDC: Centers for Disease Control and Prevention.</p> <p>Source: <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>. </p> </div> </div> <div class="table" id="CD010496-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">CDC recommended treatments for complicated vulvovaginal candidiasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Recurrent vulvovaginal candidiasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Initial regimen:</b> </p> <p>7‐14 days of any topical azole drug</p> <p>OR</p> <p>Fluconazole 100 mg, 150 mg or 200 mg orally once daily every 3rd day for a total of 3 doses (days 1, 4 and 7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maintenance regimen:</b> </p> <p>Fluconazole 100 mg, 150 mg or 200 mg orally once weekly for 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Severe vulvovaginal candidiasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Intravaginally once daily for 7 to 14 days of any topical azole drug</p> <p>OR</p> <p>Fluconazole 150 mg orally once daily in 2 doses (second dose 72 hours after initial dose) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Non‐albicans vulvovaginal candidiasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Non‐fluconazole azole (oral or topical)</p> <p>7‐14 days</p> <p>OR</p> <p>Boric acid gelatin capsule</p> <p>Intravaginally once daily for 14 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Abnormal host</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>More prolonged (i.e. 7‐14 days) conventional antifungal drugs is necessary</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CDC: Centers for Disease Control and Prevention.</p> <p>Source: <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>. </p> </div> </div> <p>Azole antifungals are a group of fungistatic agents with broad‐spectrum activity in treating systemic and topical fungal infections. They are classified into two groups: triazoles and imidazoles (<a href="./references#CD010496-bbs2-0055" title="NurbhaiM , GrimshawJ , WatsonM , BondC , MollisonJ , LudbrookA . Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD002845.pub2] ">Nurbhai 2007</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). One Cochrane systematic review showed that both imidazole and triazole antifungal treatment (by oral or intravaginal route of administration) achieved clinical cure in over 80% of women (<a href="./references#CD010496-bbs2-0055" title="NurbhaiM , GrimshawJ , WatsonM , BondC , MollisonJ , LudbrookA . Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD002845.pub2] ">Nurbhai 2007</a>). However, they can cause many adverse effects, including vomiting, diarrhea, abdominal pain, urination, pelvic cramps, paresthesia, rhinorrhea, headache, dizziness, fever, chills, vaginal burning, stinging, itching and irritation (<a href="./references#CD010496-bbs2-0055" title="NurbhaiM , GrimshawJ , WatsonM , BondC , MollisonJ , LudbrookA . Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD002845.pub2] ">Nurbhai 2007</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>); more systemic adverse effects are likely to be reported with oral compared with intravaginal antifungal administration (<a href="./references#CD010496-bbs2-0055" title="NurbhaiM , GrimshawJ , WatsonM , BondC , MollisonJ , LudbrookA . Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD002845.pub2] ">Nurbhai 2007</a>). For the half‐life, duration and any known interactions with other drugs of all azole antifungals for VVC, we recommend following this <i>Merck Manual</i> (<a href="http://www.merckmanuals.com/professional/infectious-diseases/fungi/antifungal-drugs?qt=%26sc=%26alt=#top" target="_blank">www.merckmanuals.com</a>), to reference further information. </p> <p>Probiotics confer a wide range of effects, and have been used for the prevention and treatment of various medical conditions and to support wellness. Some of their effects against diarrheal diseases, Crohn disease, ulcerative colitis, irritable bowel syndrome, bacterial vaginosis, VVC and urinary tract infections have been validated (<a href="./references#CD010496-bbs2-0071" title="ReidG , HammondJA . Probiotics: some evidence of their effectiveness. Canadian Family Physician2005;51(11):1487‐93. ">Reid 2005</a>; <a href="./references#CD010496-bbs2-0079" title="SenokAC ,  IsmaeelAY ,  BottaGA . Probiotics: facts and myths. Clinical Microbiology and Infection2005;11(12):958‐66. ">Senok 2005</a>; <a href="./references#CD010496-bbs2-0035" title="DoronS ,  GorbachSL . Probiotics: their role in the treatment and prevention of disease. Expert Review of Anti‐Infective Therapy2006;4(2):261‐75. ">Doron 2006</a>; <a href="./references#CD010496-bbs2-0077" title="SantosaS ,  FarnworthE ,  JonesPJ . Probiotics and their potential health claims. Nutrition Reviews2006;64(6):265‐74. ">Santosa 2006</a>; <a href="./references#CD010496-bbs2-0075" title="SandersME . Probiotics: definition, sources, selection, and uses. Clinical Infectious Diseases2008;46(Suppl 2):S58‐61. ">Sanders 2008</a>; <a href="./references#CD010496-bbs2-0080" title="SenokA , VerstraelenH , TemmermanM , BottaG . Probiotics for the treatment of bacterial vaginosis. Cochrane Database of Systematic Reviews2008, Issue 12. [DOI: 10.1002/14651858.CD006289.pub2] ">Senok 2008</a>). Probiotics are defined as live microorganisms that, when administered in adequate amounts, exert a health benefit on the host by treating and preventing diseases, they are regulated as dietary supplements and foods, consisting of bacteria or yeast, and they are available as capsules, tablets or powders, and may contain a single microorganism or a mixture of several species (<a href="./references#CD010496-bbs2-0067" title="ReidG , JassJ , SebulskyMT , McCormickJK . Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews2003;16(4):658‐72. ">Reid 2003a</a>; <a href="./references#CD010496-bbs2-0037" title="FalagasME , BetsiGI , AthanasiouS . Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy2006;58(2):266‐72. ">Falagas 2006</a>; <a href="./references#CD010496-bbs2-0059" title="OthmanM , NeilsonJP , AlfirevicZ . Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD005941.pub2] ">Othman 2007</a>; <a href="./references#CD010496-bbs2-0075" title="SandersME . Probiotics: definition, sources, selection, and uses. Clinical Infectious Diseases2008;46(Suppl 2):S58‐61. ">Sanders 2008</a>). <a href="#CD010496-tbl-0005">Table 4</a> lists common microorganisms used as probiotics (<a href="./references#CD010496-bbs2-0050" title="Kopp‐HoolihanL . Prophylactic and therapeutic uses of probiotics: a review. Journal of the American Dietetic Association2001;101(2):229‐38. ">Kopp‐Hoolihan 2001</a>; <a href="./references#CD010496-bbs2-0079" title="SenokAC ,  IsmaeelAY ,  BottaGA . Probiotics: facts and myths. Clinical Microbiology and Infection2005;11(12):958‐66. ">Senok 2005</a>; <a href="./references#CD010496-bbs2-0035" title="DoronS ,  GorbachSL . Probiotics: their role in the treatment and prevention of disease. Expert Review of Anti‐Infective Therapy2006;4(2):261‐75. ">Doron 2006</a>; <a href="./references#CD010496-bbs2-0077" title="SantosaS ,  FarnworthE ,  JonesPJ . Probiotics and their potential health claims. Nutrition Reviews2006;64(6):265‐74. ">Santosa 2006</a>). Products containing bacteria or yeast are not classified as probiotics, unless they have been shown to be viable and stable at the time of use in sufficient quantity to exert a health benefit. The organisms themselves must be speciated using appropriate molecular methods, and given a designation (<a href="./references#CD010496-bbs2-0071" title="ReidG , HammondJA . Probiotics: some evidence of their effectiveness. Canadian Family Physician2005;51(11):1487‐93. ">Reid 2005</a>; <a href="./references#CD010496-bbs2-0079" title="SenokAC ,  IsmaeelAY ,  BottaGA . Probiotics: facts and myths. Clinical Microbiology and Infection2005;11(12):958‐66. ">Senok 2005</a>; <a href="./references#CD010496-bbs2-0035" title="DoronS ,  GorbachSL . Probiotics: their role in the treatment and prevention of disease. Expert Review of Anti‐Infective Therapy2006;4(2):261‐75. ">Doron 2006</a>; <a href="./references#CD010496-bbs2-0077" title="SantosaS ,  FarnworthE ,  JonesPJ . Probiotics and their potential health claims. Nutrition Reviews2006;64(6):265‐74. ">Santosa 2006</a>; <a href="./references#CD010496-bbs2-0087" title="VanderhoofJA , YoungR . Probiotics in the United States. Clinical Infectious Diseases2008;46(Suppl 2):S67‐72. ">Vanderhoof 2008</a>). </p> <div class="table" id="CD010496-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Common microorganisms used as probiotics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><i><b>Lactobacillus</b> </i><b>species:</b> </p> <p><i>Lactobacillus acidophilus</i> </p> <p><i>Lactobacillus bulgaricus</i> </p> <p><i>Lactobacillus casei</i> </p> <p><i>Lactobacillus crispatus</i> </p> <p><i>Lactobacillus delbrueckii</i> </p> <p><i>Lactobacillus fermentum</i> </p> <p><i>Lactobacillus gasseri</i> </p> <p><i>Lactobacillus johnsonii</i> </p> <p><i>Lactobacillus lactis</i> </p> <p><i>Lactobacillus plantarum</i> </p> <p><i>Lactobacillus reuteri</i> </p> <p><i>Lactobacillus rhamnosus</i> GG </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Streptococcus</b> </i><b>species:</b> </p> <p>S<i>treptococcus thermophilus</i> </p> <p> </p> <p> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yeast:</b> </p> <p><i>Saccharomyces boulardii</i> </p> <p> </p> <p> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Other species:</b> </p> <p><i>Bacillus cereus</i> </p> <p><i>Enterococcus faecalisa</i> </p> <p><i>Enterococcus faeciuma</i> </p> <p><i>Escherichia coli</i> Nissle </p> <p> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Bifidobacterium</b> </i><b>species:</b> </p> <p><i>Bifidobacterium adolescentis</i> </p> <p><i>Bifidobacterium animalis</i> </p> <p><i>Bifidobacterium bifidum</i> </p> <p><i>Bifidobacterium breve</i> </p> <p><i>Bifidobacterium infantis</i> </p> <p><i>Bifidobacterium lactis</i> </p> <p><i>Bifidobacterium longum</i> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Sources: <a href="./references#CD010496-bbs2-0079" title="SenokAC ,  IsmaeelAY ,  BottaGA . Probiotics: facts and myths. Clinical Microbiology and Infection2005;11(12):958‐66. ">Senok 2005</a>; <a href="./references#CD010496-bbs2-0035" title="DoronS ,  GorbachSL . Probiotics: their role in the treatment and prevention of disease. Expert Review of Anti‐Infective Therapy2006;4(2):261‐75. ">Doron 2006</a>; <a href="./references#CD010496-bbs2-0077" title="SantosaS ,  FarnworthE ,  JonesPJ . Probiotics and their potential health claims. Nutrition Reviews2006;64(6):265‐74. ">Santosa 2006</a>. </p> </div> </div> <p>Probiotics used in the prevention and treatment of <i>Candida</i> infections include <i>Lactobacillus fermentum</i> RC‐14, <i>Lactobacillus fermentum</i> B‐54, <i>Lactobacillus rhamnosus</i> GR‐1, <i>Lactobacillus rhamnosus</i> GG and <i>Lactobacillus acidophilus</i> (<a href="./references#CD010496-bbs2-0064" title="ReidG , BruceAW . Selection of Lactobacillus strains for urogenital probiotic applications. Journal of Infectious Diseases2001;183(Suppl 1):77‐80. ">Reid 2001a</a>; <a href="./references#CD010496-bbs2-0047" title="JeavonsHS . Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus . Journal of Obstetric, Gynecologic, and Neonatal Nursing2003;32(3):287‐96. ">Jeavons 2003</a>; <a href="./references#CD010496-bbs2-0071" title="ReidG , HammondJA . Probiotics: some evidence of their effectiveness. Canadian Family Physician2005;51(11):1487‐93. ">Reid 2005</a>; <a href="./references#CD010496-bbs2-0037" title="FalagasME , BetsiGI , AthanasiouS . Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy2006;58(2):266‐72. ">Falagas 2006</a>; <a href="./references#CD010496-bbs2-0052" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009a</a>). Administration of probiotics can be oral, intravaginal or combined (<a href="./references#CD010496-bbs2-0070" title="ReidG , BurtonJ , DevillardE . The rationale for probiotics in female urogenital healthcare. Medscape General Medicine2004;6(1):49. ">Reid 2004</a>). Probiotics are safe and effective for urogenital infections, with no severe adverse effects (<a href="./references#CD010496-bbs2-0068" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology2003;35(2):131‐4. ">Reid 2003b</a>). The recommended dose is 10<sup>9</sup> to 10<sup>11</sup> colony‐forming units of bacteria, by any route of administration (<a href="./references#CD010496-bbs2-0068" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology2003;35(2):131‐4. ">Reid 2003b</a>; <a href="./references#CD010496-bbs2-0029" title="AndreuA . Lactobacillus as a probiotic for preventing urogenital infections. Reviews in Medical Microbiology2004;15:1‐6. ">Andreu 2004</a>). Probiotic preparations should not be taken together with bismuth preparations, tannic acid, activated charcoal or tincture. Because of the sensitivity of probiotics to antibiotics, they should not be taken together, to avoid dilution of their effectiveness (<a href="./references#CD010496-bbs2-0088" title="ZhangHY , LvX , LiY . Safety and clinical use of microecological preparations. Adverse Drug Reactions Journal2008;10(5):340‐5. ">Zhang 2008</a>). </p> </section> <section id="CD010496-sec-0050"> <h3 class="title" id="CD010496-sec-0050">How the intervention might work</h3> <p>The concept of treatment with probiotics stems from a belief that modern humans do not consume or replenish the beneficial microbes in their bodies, and that they can do so by taking probiotics (<a href="./references#CD010496-bbs2-0071" title="ReidG , HammondJA . Probiotics: some evidence of their effectiveness. Canadian Family Physician2005;51(11):1487‐93. ">Reid 2005</a>). The normal vaginal microenvironment is predominantly populated by <i>Lactobacillus</i> species, which tend to suppress growth of other bacterial species (<a href="./references#CD010496-bbs2-0070" title="ReidG , BurtonJ , DevillardE . The rationale for probiotics in female urogenital healthcare. Medscape General Medicine2004;6(1):49. ">Reid 2004</a>). This dominance of lactobacilli and their potential ability to resist VVC gave rise to the concept of oral or vaginal instillation of probiotic <i>Lactobacillus</i> strains to restore the vaginal microbiotic balance. After the live bacteria in probiotic preparations have colonized the vagina, they grow and reproduce, and their metabolic substances can have toxic effects on <i>Candida</i> species (<a href="./references#CD010496-bbs2-0065" title="ReidG , BruceAW , FraserN , HeinemannC , OwenJ , HenningB . Oral probiotics can resolve urogenital infections. FEMS Immunology and Medical Microbiology2001;30(1):49‐52. ">Reid 2001b</a>; <a href="./references#CD010496-bbs2-0066" title="ReidG , BeuermanD , HeinemannC , BruceAW . Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunology and Medical Microbiology2001;32(1):37‐41. ">Reid 2001c</a>; <a href="./references#CD010496-bbs2-0068" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology2003;35(2):131‐4. ">Reid 2003b</a>). Evidence suggests that oral intake of probiotics leads to transfer of the organisms from the rectum to the vagina, as well as an overall depletion of coliforms and yeasts in the vagina (<a href="./references#CD010496-bbs2-0065" title="ReidG , BruceAW , FraserN , HeinemannC , OwenJ , HenningB . Oral probiotics can resolve urogenital infections. FEMS Immunology and Medical Microbiology2001;30(1):49‐52. ">Reid 2001b</a>; <a href="./references#CD010496-bbs2-0066" title="ReidG , BeuermanD , HeinemannC , BruceAW . Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunology and Medical Microbiology2001;32(1):37‐41. ">Reid 2001c</a>; <a href="./references#CD010496-bbs2-0068" title="ReidG , CharbonneauD , ErbJ , KochanowskiB , BeuermanD , PoehnerR , et al. Oral use of Lactobacillus rhamnosus GR‐1 and L. fermentum RC‐14 significantly alters vaginal flora: randomized, placebo‐controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology2003;35(2):131‐4. ">Reid 2003b</a>). Certain probiotic strains, including <i>Lactobacillus fermentum</i> RC‐14 and <i>Lactobacillus rhamnosus</i> GR‐1, are able to remain in the vagina for several months after introduction. </p> <p>The actual mechanism of action of probiotics in the vagina is probably multifactorial; they may block and prevent the <i>Candida</i> species' colonization, adhesion, invasion and growth by lactic acid, hydrogen peroxide and bacteriocin, which are toxic to <i>Candida</i> species (<a href="./references#CD010496-bbs2-0067" title="ReidG , JassJ , SebulskyMT , McCormickJK . Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews2003;16(4):658‐72. ">Reid 2003a</a>; <a href="./references#CD010496-bbs2-0069" title="ReidG , BruceAW . Urogenital infections in women: can probiotics help?. Postgraduate Medical Journal2003;79(934):428‐32. ">Reid 2003c</a>; <a href="./references#CD010496-bbs2-0070" title="ReidG , BurtonJ , DevillardE . The rationale for probiotics in female urogenital healthcare. Medscape General Medicine2004;6(1):49. ">Reid 2004</a>; <a href="./references#CD010496-bbs2-0082" title="SobelJD . Candidal vulvovaginitis. Lancet2007;369(9577):1961‐71. ">Sobel 2007</a>). In addition, probiotics may take the action of competitive exclusion, which is caused by a stronger affinity of <i>Lactobacillus</i> than pathogens to the receptors of the vaginal epithelial cells (<a href="./references#CD010496-bbs2-0048" title="KaewsrichanJ , PeeyananjarassriK , KongprasertkitJ . Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunology and Medical Microbiology2006;48(1):75‐83. ">Kaewsrichan 2006</a>). The inflammatory temperance effect, provided by stable colonization with probiotics in the vagina, may help to regulate the vaginal immune environment (<a href="./references#CD010496-bbs2-0038" title="FichorovaRN , YamamotoHS , DelaneyML , OnderdonkAB , DoncelGF . Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio2011;2(6):e00168‐11. ">Fichorova 2011</a>; <a href="./references#CD010496-bbs2-0073" title="RoseWA2nd , McGowinCL , SpagnuoloRA , Eaves‐PylesTD , PopovVL , PylesRB . Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. PloS One2012;7(3):e32728. ">Rose 2012</a>). It has also been shown that <i>Lactobacillus rhamnosus</i> GR‐1 and <i>Lactobacillus reuteri</i> RC‐14 may directly influence the response of the vaginal epithelial cells to <i>Candida albicans</i> infections (<a href="./references#CD010496-bbs2-0069" title="ReidG , BruceAW . Urogenital infections in women: can probiotics help?. Postgraduate Medical Journal2003;79(934):428‐32. ">Reid 2003c</a>; <a href="./references#CD010496-bbs2-0070" title="ReidG , BurtonJ , DevillardE . The rationale for probiotics in female urogenital healthcare. Medscape General Medicine2004;6(1):49. ">Reid 2004</a>; <a href="./references#CD010496-bbs2-0053" title="MartinezRC ,  SeneySL ,  SummersKL ,  NomizoA ,  De MartinisEC ,  ReidG . Effect of Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiology and Immunology2009;53(9):487‐95. ">Martinez 2009b</a>). After eliminating most of the <i>Candidas</i> , <i>Lactobacillus</i> could restore and maintain a normal vaginal microenvironment to prevent recurrence (<a href="./references#CD010496-bbs2-0067" title="ReidG , JassJ , SebulskyMT , McCormickJK . Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews2003;16(4):658‐72. ">Reid 2003a</a>; <a href="./references#CD010496-bbs2-0069" title="ReidG , BruceAW . Urogenital infections in women: can probiotics help?. Postgraduate Medical Journal2003;79(934):428‐32. ">Reid 2003c</a>; <a href="./references#CD010496-bbs2-0070" title="ReidG , BurtonJ , DevillardE . The rationale for probiotics in female urogenital healthcare. Medscape General Medicine2004;6(1):49. ">Reid 2004</a>; <a href="./references#CD010496-bbs2-0071" title="ReidG , HammondJA . Probiotics: some evidence of their effectiveness. Canadian Family Physician2005;51(11):1487‐93. ">Reid 2005</a>). </p> </section> <section id="CD010496-sec-0051"> <h3 class="title" id="CD010496-sec-0051">Why it is important to do this review</h3> <p>A growing number of women are troubled by the high prevalence and recurrence rates of VVC (<a href="./references#CD010496-bbs2-0052" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009a</a>). Although anticandidal agents are quite effective at providing clinical cure for VVC, resistance to the drugs is increasing. In addition, drugs may reduce the normal protective vaginal flora to increase the risk of recurrent infection, and can also cause many adverse effects (<a href="./references#CD010496-bbs2-0055" title="NurbhaiM , GrimshawJ , WatsonM , BondC , MollisonJ , LudbrookA . Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD002845.pub2] ">Nurbhai 2007</a>; <a href="./references#CD010496-bbs2-0052" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009a</a>; <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>). The increasing availability of probiotic products makes it important that family physicians understand what to look for when making recommendations (<a href="./references#CD010496-bbs2-0071" title="ReidG , HammondJA . Probiotics: some evidence of their effectiveness. Canadian Family Physician2005;51(11):1487‐93. ">Reid 2005</a>). The use of probiotics in augmenting normal bacterial populations is gradually achieving scientific acceptance (<a href="./references#CD010496-bbs2-0069" title="ReidG , BruceAW . Urogenital infections in women: can probiotics help?. Postgraduate Medical Journal2003;79(934):428‐32. ">Reid 2003c</a>). Probiotics have already been used for treatment of vulvovaginal inflammations in clinical practice (<a href="./references#CD010496-bbs2-0064" title="ReidG , BruceAW . Selection of Lactobacillus strains for urogenital probiotic applications. Journal of Infectious Diseases2001;183(Suppl 1):77‐80. ">Reid 2001a</a>; <a href="./references#CD010496-bbs2-0067" title="ReidG , JassJ , SebulskyMT , McCormickJK . Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews2003;16(4):658‐72. ">Reid 2003a</a>; <a href="./references#CD010496-bbs2-0069" title="ReidG , BruceAW . Urogenital infections in women: can probiotics help?. Postgraduate Medical Journal2003;79(934):428‐32. ">Reid 2003c</a>; <a href="./references#CD010496-bbs2-0059" title="OthmanM , NeilsonJP , AlfirevicZ . Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD005941.pub2] ">Othman 2007</a>). Some evaluations have shown that probiotics are effective against VVC, and that their adverse effects are minor (<a href="./references#CD010496-bbs2-0047" title="JeavonsHS . Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus . Journal of Obstetric, Gynecologic, and Neonatal Nursing2003;32(3):287‐96. ">Jeavons 2003</a>; <a href="./references#CD010496-bbs2-0037" title="FalagasME , BetsiGI , AthanasiouS . Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy2006;58(2):266‐72. ">Falagas 2006</a>; <a href="./references#CD010496-bbs2-0052" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009a</a>), while others demonstrated no efficacy in VVC (<a href="./references#CD010496-bbs2-0062" title="PirottaM , GunnJ , ChondrosP , GroverS , O'MalleyP , HurleyS , et al. Effect of Lactobacillus in preventing post‐antibiotic vulvovaginal candidiasis: a randomized controlled trial. BMJ2004;329:548‐52. ">Pirotta 2004</a>; <a href="./references#CD010496-bbs2-0037" title="FalagasME , BetsiGI , AthanasiouS . Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. Journal of Antimicrobial Chemotherapy2006;58(2):266‐72. ">Falagas 2006</a>). There is no consensus on the use of probiotics for treating VVC (<a href="./references#CD010496-bbs2-0047" title="JeavonsHS . Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus . Journal of Obstetric, Gynecologic, and Neonatal Nursing2003;32(3):287‐96. ">Jeavons 2003</a>; <a href="./references#CD010496-bbs2-0086" title="VanKesselK , AssefiN , MarrazzoJ , EckertL . Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review. Obstetrical &amp; Gynecological Survey2003;58(5):351‐8. ">Van Kessel 2003</a>). Therefore, it is necessary to conduct a rigorous systematic review of the available clinical trials, to help determine the effectiveness and safety of probiotics for the treatment of VVC, and to identify strategic areas for future research. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010496-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010496-sec-0052">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010496-sec-0154">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010496-sec-0052"></div> <p>To assess the effectiveness and safety of probiotics for the treatment of vulvovaginal candidiasis in non‐pregnant women. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010496-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010496-sec-0053">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010496-sec-0155">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010496-sec-0053"></div> <section id="CD010496-sec-0054"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010496-sec-0055"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCT). We excluded quasi‐randomized trials because such trials produce effects estimates that indicate more extreme benefits when they are compared with RCTs (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We excluded cross‐over trials because the carry over effect (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD010496-sec-0056"> <h4 class="title">Types of participants</h4> <p>Non‐pregnant women diagnosed with VVC, regardless of age and race. Diagnosis of VVC was confirmed by the presence of clinical symptoms and signs, and a positive microscopic examination or positive vaginal culture, or both. </p> <p>We excluded trials of women with RVVC, diabetes mellitus, immunosuppressive disorders; taking immunosuppressant medication; or trials that recruited women with evidence of coinfection with other vulvovaginal infections. </p> </section> <section id="CD010496-sec-0057"> <h4 class="title">Types of interventions</h4> <p>Any probiotic: single or multiple strains, any preparation type, dosage regimen or route of administration. </p> <p> <ul id="CD010496-list-0005"> <li> <p>Used alone versus conventional antifungal drugs.</p> </li> <li> <p>Used as adjuvants to conventional antifungal drugs (before, during or after antifungal treatment) versus conventional antifungal drugs alone. </p> </li> </ul> </p> <p>Conventional antifungal drugs described here refer to the common drugs for VVC treatment, such as azole drugs (triazoles and imidazoles) and nystatin. </p> </section> <section id="CD010496-sec-0058"> <h4 class="title">Types of outcome measures</h4> <section id="CD010496-sec-0059"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010496-list-0006"> <li> <p>Clinical cure rate (disappearance of symptoms and signs, and no evidence of fungal infection proved by microscopic examination or vaginal culture), split into 'short‐term clinical cure rate' (zero to 14 days after treatment) and 'long‐term clinical cure rate' (one, three and six months after treatment). </p> </li> <li> <p>Mycological cure rate (no evidence of fungal infection proved by microscopic examination or vaginal culture), split into 'short‐term mycological cure rate' (zero to 14 days after treatment)' and 'long‐term mycological cure rate' (one, three and six months after treatment). </p> </li> <li> <p>Relapse rate (symptom recurrence confirmed by microscopic examination or vaginal culture at one, three and six after mycological cure). </p> </li> <li> <p>Rate of serious adverse events (death, internal organ injury, severe skin and mucosal injury). </p> </li> </ul> </p> </section> <section id="CD010496-sec-0060"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010496-list-0007"> <li> <p>Time to first relapse.</p> </li> <li> <p>Rate of non‐serious adverse events (mild symptoms include vomiting, diarrhea, abdominal pain, abnormal urination, pelvic cramps, paresthesia, rhinorrhea, headache, dizziness, fever, chills, vaginal burning, stinging, itching and irritation). </p> </li> <li> <p>Need for any additional treatment at the end of therapy.</p> </li> <li> <p>Patient satisfaction with treatment.</p> </li> <li> <p>Cost effectiveness.</p> </li> </ul> </p> </section> </section> </section> <section id="CD010496-sec-0061"> <h3 class="title">Search methods for identification of studies</h3> <p>We attempted to identify as many relevant RCTs as possible of "probiotics" for "VVC", regardless of language, publication date or publication status (published, unpublished, in press and in progress). We used both electronic searching in bibliographic databases and handsearching, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <section id="CD010496-sec-0062"> <h4 class="title">Electronic searches</h4> <p>We contacted the Information Specialist of the Cochrane Sexually Transmitted Infections Group to implement a comprehensive search strategy to identify as many relevant RCTs as possible in the electronic databases. The search strategies included a combination of controlled vocabulary (MeSH, EMTREE, DeCS, including exploded terms) and free‐text terms for "probiotics" and "VVC", with field labels (title and abstract), wildcards (truncation), proximity operators (adj) and boolean operators (OR, AND). </p> <p>We searched the following electronic databases:</p> <p> <ul id="CD010496-list-0008"> <li> <p>Sexually Transmitted Infections Cochrane Review Group's Specialized Register (to October 2017); </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), Ovid (1991 to October 2017);</p> </li> <li> <p>MEDLINE, Ovid (1946 to October 2017);</p> </li> <li> <p>MEDLINE In‐Process &amp; Other Non‐Indexed Citations, Ovid (1946 to October 2017);</p> </li> <li> <p>MEDLINE Daily Update, Ovid (1946 to October 2017);</p> </li> <li> <p>Embase (1947 to October 2017);</p> </li> <li> <p>LILACS, IAHx interface (1982 to October 2017);</p> </li> <li> <p>PsycINFO, Ovid (1946 to October 2017);</p> </li> <li> <p>AMED, Ovid (1946 to October 2017);</p> </li> <li> <p>CBMdisc and CNKI: inception to October 2017.</p> </li> </ul> </p> <p>The search strategies for the STI Specialized Register, CENTRAL, MEDLINE, Embase, AMED, CBMdisc and CNKI, PsycINFO and LILACS can be found in <a href="./appendices#CD010496-sec-0127">Appendix 1</a>, <a href="./appendices#CD010496-sec-0128">Appendix 2</a>, <a href="./appendices#CD010496-sec-0129">Appendix 3</a>, <a href="./appendices#CD010496-sec-0130">Appendix 4</a>, <a href="./appendices#CD010496-sec-0131">Appendix 5</a>, <a href="./appendices#CD010496-sec-0132">Appendix 6</a>, and <a href="./appendices#CD010496-sec-0133">Appendix 7</a>. </p> <p>We placed no language restrictions.</p> </section> <section id="CD010496-sec-0063"> <h4 class="title">Searching other resources</h4> <p>We attempted to identify other published, unpublished and ongoing relevant RCTs by:</p> <p> <ul id="CD010496-list-0009"> <li> <p>searching trials registers:</p> <ul id="CD010496-list-0010"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>); </p> </li> </ul> </li> <li> <p>searching Web of Science (inception to October 2017);</p> </li> <li> <p>searching grey literature in System for Information on Grey Literature in Europe "OpenGrey" (<a href="http://www.opengrey.eu/" target="_blank">www.opengrey.eu/</a>) (inception to October 2017); </p> </li> <li> <p>contacting authors of included RCTs and experts in the field to identify any additional published and unpublished materials; </p> </li> <li> <p>contacting pharmaceutical companies producing "probiotics" for "VVC";</p> </li> <li> <p>handsearching the following journals: <i>Anatolian Journal of Obstetrics &amp; Gynecology</i> , <i>Current Medical Literature Gynecology &amp; Obstetrics</i> , <i>Current Obstetrics and Gynecology Reports</i> , <i>ISRN Obstetrics and Gynecology</i> , <i>Journal of South Asian Federation of Obstetrics &amp; Gynecology</i> , <i>Obstetrics and Gynecology International</i> , <i>Obstetrics Gynaecology and Reproductive Medicine</i> and <i>Sexual Science: the newsletter of the Society for the Scientific Study of Sexuality and Sexualities</i>; </p> </li> <li> <p>handsearching the conference proceeding abstracts in the following events:</p> <ul id="CD010496-list-0011"> <li> <p>International Society for Sexually Transmitted Diseases Research (ISSTDR) (<a href="http://www.isstdr.org/" target="_blank">www.isstdr.org/</a>): 2007, 2009, 2011, 2013 and 2015; </p> </li> <li> <p>British Association for Sexual Health and HIV (BASHH) (<a href="http://www.bashh.org/" target="_blank">www.bashh.org/</a>): 2004, 2006, 2007, 2009, 2010, 2011 and 2014; </p> </li> <li> <p>International Congress on Infectious Diseases (ICID) (<a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2010, 2012 and 2014; </p> </li> <li> <p>International Union against Sexually Transmitted Infections (IUSTI) (<a href="http://www.iusti.org/" target="_blank">www.iusti.org/</a>): 2011, 2012, 2013 and 2014; </p> </li> <li> <p>International Society for Infectious Diseases (ISID) (<a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2011; </p> </li> <li> <p>International Meeting on Emerging Diseases and Surveillance (IMED) (<a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2007, 2009, 2013 and 2014; </p> </li> <li> <p>Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (<a href="http://www.icaac.org/" target="_blank">www.icaac.org/</a>): 2011, 2012, 2013, 2014 and 2015; </p> </li> <li> <p>International Federation of Gynecology and Obstetrics (FIGO) (<a href="http://www.figo.org" target="_blank">www.figo.org</a>): 2012 and 2015; </p> </li> </ul> </li> <li> <p>handsearching previous systematic reviews and other relevant publications on the same topic; </p> </li> <li> <p>handsearching reference lists of all RCTs identified by other methods, including available review articles on the topic, and contacting authors of all RCTs identified by other methods. </p> </li> </ul> </p> </section> </section> <section id="CD010496-sec-0064"> <h3 class="title" id="CD010496-sec-0064">Data collection and analysis</h3> <section id="CD010496-sec-0065"> <h4 class="title">Selection of studies</h4> <p>Two authors (DW and HC) independently scanned all titles and abstracts from the initial search, to exclude trials that did not meet the inclusion criteria. Multiple reports of the same study were collected and collated so that each study, rather than each report, was used. Two authors (DW and HC) independently assessed the full text of trials that appeared to meet the inclusion criteria. Two authors (DW and HC) contacted the authors of articles if any important information was missing. We resolved any discrepancies through discussion with a third author (HX). </p> </section> <section id="CD010496-sec-0066"> <h4 class="title">Data extraction and management</h4> <p>Two authors (LM and XW) independently extracted data using a previously designed form for this review. The data extraction form was pilot tested using one of the included studies. We collected the following information. </p> <p> <ul id="CD010496-list-0012"> <li> <p>Study characteristics.</p> <ul id="CD010496-list-0013"> <li> <p>Year and language of publication.</p> </li> <li> <p>Inclusion and exclusion criteria.</p> </li> <li> <p>Randomization process.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding.</p> </li> <li> <p>Number of withdrawals (participants excluded from analysis or lost to follow‐up) and reasons. </p> </li> <li> <p>Intention‐to‐treat analysis.</p> </li> <li> <p>Duration of follow‐up.</p> </li> </ul> </li> <li> <p>Basic participant information.</p> <ul id="CD010496-list-0014"> <li> <p>Number.</p> </li> <li> <p>Mean age and age range of the participants.</p> </li> <li> <p>Type of participants (health status, uncomplicated VVC or complicated VVC).</p> </li> </ul> </li> <li> <p>Intervention.</p> <ul id="CD010496-list-0015"> <li> <p>Drug.</p> </li> <li> <p>Type (single or multiple).</p> </li> <li> <p>Preparation.</p> </li> <li> <p>Dosage and route of administration.</p> </li> </ul> </li> <li> <p>Outcome.</p> <ul id="CD010496-list-0016"> <li> <p>Clinical cure rate.</p> </li> <li> <p>Mycological cure rate.</p> </li> <li> <p>Relapse rate.</p> </li> <li> <p>Time to first relapse.</p> </li> </ul> </li> <li> <p>Adverse events.</p> <ul id="CD010496-list-0017"> <li> <p>Serious adverse events.</p> </li> <li> <p>Non‐serious adverse events.</p> </li> </ul> </li> <li> <p>Cost effectiveness: if the data were mentioned and available.</p> </li> <li> <p>Others.</p> <ul id="CD010496-list-0018"> <li> <p>Funding sources reported.</p> </li> <li> <p>Ethical issues: use of signed informed consent and ethics approval.</p> </li> </ul> </li> </ul> </p> <p>We discussed any disagreements referring back to the trial report until we reached consensus. If data from the trial reports were insufficient or missing, we contacted the trial authors for additional information. </p> <p>Two authors (LM, XW) entered data into Review Manager 5 (<a href="./references#CD010496-bbs2-0072" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and a third author (HX) checked them to ensure data quality. When information regarding any of the above were unclear, we contacted the authors of the studies to ask for further details. For a single randomized controlled clinical trial report, we extracted data directly onto the data extraction form and in case of multiple reports, we extracted data from each report separately and then combined them across the forms. Studies reported a language other than English or Chinese were translated. </p> </section> <section id="CD010496-sec-0067"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (DW and HC) assessed the methodological quality of each trial using the Cochrane 'Risk of bias' tool. We resolved any disagreements by consensus or by involving a third author (FF). The authors assessing risk of bias were thematic and methodology experts. We assessed the following information which was used for the development of the 'Risk of bias' tables. </p> <p> <ul id="CD010496-list-0019"> <li> <p><b>1. Random sequence generation</b> (checking for possible selection bias). We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. We assessed the method as: low risk of bias (any truly random process, e.g. random number table, computer random number generator); high risk of bias (any non‐random process, e.g. odd or even date of birth, hospital or clinic record number) or unclear risk of bias. </p> </li> <li> <p><b>2. Allocation concealment</b> (checking for possible selection bias). We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during, recruitment, or changed after assignment. We assessed the methods as: low risk of bias (e.g. telephone or central randomization, consecutively numbered sealed opaque envelopes); high risk of bias (open random allocation, unsealed or non‐opaque envelopes, alternation, date of birth) or unclear risk of bias. </p> </li> <li> <p><b>3. Blinding</b> </p> <ul id="CD010496-list-0020"> <li> <p><b>3.1 Blinding of participants and personnel</b> (checking for possible performance bias). We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. We assessed the methods as: low, high or unclear risk of bias for participants; and low, high or unclear risk of bias for personnel. </p> </li> <li> <p><b>3.2 Blinding of outcome assessment</b> (checking for possible detection bias). We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. We assessed methods used to blind outcome assessment as low, high or unclear risk of bias. </p> </li> </ul> </li> <li> <p><b>4. Incomplete outcome data</b> (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data). We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We reported whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomized participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we reincluded missing data in the analyses that we undertook. We assessed methods as low risk of bias (e.g. no missing outcome data, missing outcome data balanced across groups); high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups, 'as treated' analysis done with substantial departure of intervention received from that assigned at randomization) or unclear risk of bias. We used a cut‐off point of 20% to consider that a study was at low or high risk of bias according to the level of missing data. </p> </li> <li> <p><b>5. Selective reporting</b> (checking for reporting bias). We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. We assessed the methods as: low risk of bias (where it was clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review were reported); high risk of bias (where not all the study's prespecified outcomes were reported, one or more reported primary outcomes were not prespecified, outcomes of interest were reported incompletely and so could not be used, study failed to include results of a key outcome that would have been expected to have been reported or unclear risk of bias). </p> </li> <li> <p><b>6. Other bias</b> (checking for bias due to problems not covered under points 1 to 5 above). We described for each included study any important concerns we had about other possible sources of bias (stopped early due to some data‐dependent process or extreme baseline imbalance or was claimed to be fraudulent or have been sponsored by industry). We assessed whether each study was free of other problems that could put it at risk of bias. </p> </li> <li> <p><b>7. Overall risk of bias</b>. We made explicit judgments about whether studies are at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). With reference to points 1 to 6 above, we assessed the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings. </p> </li> </ul> </p> <p>Two authors (DW and HC) independently applied the 'Risk of bias' tool, and resolved differences by discussion or by discussion with a third author (FF). We presented results in a 'Risk of bias' graph. The risk of bias findings were used to inform any meta‐analyses. </p> </section> <section id="CD010496-sec-0068"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes, we pooled the results in meta‐analyses and presented results as summary risk ratios (RRs) with 95% confidence intervals (CIs). We expressed continuous data as mean differences (MDs) with 95% CIs. </p> </section> <section id="CD010496-sec-0069"> <h4 class="title">Unit of analysis issues</h4> <p>The primary unit of analysis in meta‐analysis was the participant. For trials that contributed multiple, correlated comparisons, we planned to combine all relevant experimental intervention groups of the trials into a single group and combined all relevant control intervention groups into a single control group so we could create a single pair‐wise comparison (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>) when the objective was to compare the experimental branch with any other control group. </p> </section> <section id="CD010496-sec-0070"> <h4 class="title">Dealing with missing data</h4> <p>Whenever possible, we contacted the original authors to request missing data. We identified levels of attrition for included trials and we performed analyses for all outcomes, as far as possible, on an intention‐to‐treat basis. We attempted to include all participants randomized to each group in the analyses, and all participants were analyzed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. We conducted sensitivity analyses to explore the impact of studies with missing data, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD010496-sec-0071"> <h4 class="title">Assessment of heterogeneity</h4> <p>If there was obvious heterogeneity (populations, interventions, etc.), we conducted subgroup analyses to investigate potential sources of heterogeneity. We assessed statistical heterogeneity in each meta‐analysis using the T<sup>2</sup>, I<sup>2</sup> and Chi<sup>2</sup> statistics. We regarded heterogeneity as substantial if the I² statistic was greater than 40% and either T<sup>2</sup> was greater than zero or there was a low P value (less than 0.10) in the Chi<sup>2</sup> test for heterogeneity. </p> </section> <section id="CD010496-sec-0072"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess reporting bias by constructing a funnel plot. If 10 or more original trials were identified, then a funnel plot would be produced in an attempt to identify any publication bias. However, for each outcome, we included fewer than 10 trials in the meta‐analysis, so we did not perform these analyses. </p> </section> <section id="CD010496-sec-0073"> <h4 class="title">Data synthesis</h4> <p>We performed the statistical analyses by using Review Manager 5 (<a href="./references#CD010496-bbs2-0072" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). If the trials were judged to be similar, and in the absence of statistical heterogeneity, we pooled the data using a fixed‐effect model, and if statistical heterogeneity was present, we used a random‐effect model. If the outcome data could not be combined, we described the outcome separately. If the data were available, we conducted time‐to‐event analyses for time to recurrence by extracting data from published curves (<a href="./references#CD010496-bbs2-0061" title="ParmarMKB , TorriV , StewartL . Extracting summary statistics to perform meta‐analysis of the published literature for survival endpoints. Statistics in Medicine1998;17:2815‐34. ">Parmar 1998</a>). We assessed the quality of the body of evidence. </p> <p>Because the Chi<sup>2</sup> test has low power when sample sizes or number of studies are small, it may fail to detect heterogeneity. In the event of few trials or small samples, we proposed to conduct both a random‐effects and a fixed‐effect meta‐analysis, even if there was no heterogeneity detected. </p> <section id="CD010496-sec-0074"> <h5 class="title">'Summary of findings' table</h5> <p>We summarized the results for the main comparison in a 'Summary of findings' table. We used the GRADE approach to assess the quality of evidence in relation to each outcome included) and used GRADE profiler (GRADEpro) software to import data from Review Manager 5 (<a href="./references#CD010496-bbs2-0072" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to create a 'Summary of findings' table (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>We produced a 'Summary of findings' table for eight critical outcomes in each type of comparison: </p> <p> <ul id="CD010496-list-0021"> <li> <p>clinical cure rate (short‐term);</p> </li> <li> <p>clinical cure rate (long‐term/one month after treatment);</p> </li> <li> <p>clinical cure rate (long‐term/three months after treatment);</p> </li> <li> <p>mycological cure rate (short‐term);</p> </li> <li> <p>mycological cure rate (long‐term/one month after treatment);</p> </li> <li> <p>mycological cure rate (long‐term/three months after treatment);</p> </li> <li> <p>relapse rate;</p> </li> <li> <p>rate of serious adverse events.</p> </li> </ul> </p> <p>For each outcome, quality was categorized into four ratings: high quality (further research is very unlikely to change our confidence in the estimate of effect), moderate quality (further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate), low quality (further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate) and very low quality (we are very uncertain about the estimate) (<a href="./references#CD010496-bbs2-0044" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> </section> <section id="CD010496-sec-0075"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We explored a subgroup analysis in cases of high heterogeneity and assessed the effect of certain subgroups for all outcomes: </p> <p> <ul id="CD010496-list-0022"> <li> <p>probiotics: single versus multiple species;</p> </li> <li> <p>route of administration: intravaginal versus oral;</p> </li> <li> <p>different candidal strains: <i>Candida albicans</i> versus non‐albicans; </p> </li> <li> <p>age group of participants: aged less than 18 years versus aged 18 years or greater.</p> </li> </ul> </p> </section> <section id="CD010496-sec-0076"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform a sensitivity analysis to explore whether the results of the review were robust, depending on study quality, for each outcome variable. We excluded studies with a high risk of bias, comparing findings within the remainder of the included studies with the original meta‐analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010496-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010496-sec-0077"></div> <section id="CD010496-sec-0078"> <h3 class="title">Description of studies</h3> <section id="CD010496-sec-0079"> <h4 class="title">Results of the search</h4> <p>We searched the available literature up to October 2017 and retrieved 2525 references, of which we screened 2481 after we removed duplicates. We excluded 2454 clearly irrelevant references. We screened the full‐text articles of the remaining 27 references. Ten published trials met our inclusion criteria (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). We excluded 16 studies (see <a href="./references#CD010496-sec-0144" title="">Characteristics of excluded studies</a> table) and one trial is awaiting classification (see the <a href="./references#CD010496-sec-0145" title="">Characteristics of studies awaiting classification</a> table). We presented a PRISMA diagram in <a href="#CD010496-fig-0001">Figure 1</a> to illustrate the study selection process. </p> <div class="figure" id="CD010496-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram. RCT: randomized controlled trial." data-id="CD010496-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram. RCT: randomized controlled trial.</p> </div> </div> </div> </section> <section id="CD010496-sec-0080"> <h4 class="title">Included studies</h4> <p>We included 10 trials in this review (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>), and included data from 1656 women, with a sample size ranging from 68 to 436 participants. These trials were from China (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), Bulgaria (<a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>), Brazil (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>), and Iran (<a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). Only one was multicentric trial (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>). Seven trials were published in Chinese (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), and three trials were published in English (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). </p> <section id="CD010496-sec-0081"> <h5 class="title">Population</h5> <p>Study populations were heterogeneous. The included trials recruited participants aged between 16 and 50 years. All trials used at least one laboratory method for diagnosis. All the selected trials recruited participants without RVVC, diabetes mellitus, immunosuppressive disorders, taking immunosuppressant medication or evidence of co‐infection with other vulvovaginal infections. One trial implemented an added exclusion criterion related with human papillomavirus infection (<a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). Two trials only recruited married participants (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). Three trials required that participants had no sexual activity during treatment and follow‐up (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>), five trials required participants had no sexual activity during treatment and used a condom during follow‐up (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), and two trials did not mention the requirement of sexual activity (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> </section> <section id="CD010496-sec-0082"> <h5 class="title">Interventions</h5> <p>All trials used probiotics as adjuvant therapy to antifungal drugs. Five trials used probiotics of <i>Lactobacillus delbrueckii</i> subsp. Lactis DM8909 (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), two trials used probiotics of <i>Streptococcus faecalis</i> (<a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>), one trial used probiotics of <i>Lactobacillus rhamnosus</i> GR‐1 and <i>Lactobacillus reuteri</i> RC‐14 (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>), one trial used probiotics of <i>Lactobacillus acidophilus</i> , <i>Lactobacillus rhamnosus</i> , <i>Streptococcus thermophilus</i> and <i>Lactobacillus delbrueckii</i> subsp. Bulgaricus (<a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>), and one trial used probiotics contained seven strains of probiotic bacteria (<i>Lactobacillus casei</i> , <i>Lactobacillus rhamnosus</i> , <i>Streptococcus thermophilus</i> , <i>Bifidobacterium breve</i> , <i>Lactobacillus acidophilus</i> , <i>Bifidobacterium longum</i> and <i>Lactobacillus bulgaricus</i>) (<a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> <p>The most frequently used conventional antifungal drug was clotrimazole (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), three trials used miconazole (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>), two trials used fluconazole (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>), and one trial used fluconazole plus fenticonazole (<a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). <a href="#CD010496-tbl-0006">Table 5</a> lists a brief summary of interventions in included studies. </p> <div class="table" id="CD010496-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Brief summary of interventions in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Included study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intervention groups</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intervention doses and duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intervention administration route</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4 + 1 capsule of <i>Lactobacillus delbrueckii</i> Subsp. Lactis DM8909 (each capsule contained 0.25 × 10<sup>6</sup> colony forming units), QD from day 1 to day 10. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 400 mg, QD from day 1 to day 6, and then 1 capsule of <i>Lactobacillus delbrueckii s</i>ubsp. Lactis DM8909 (each capsule contained 0.25 × 10<sup>6</sup> colony forming units), QD from day 7 to day 16. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 vaginal suppository of Miconazole nitrate (400 mg), QD from day 1 to day 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Azole + vaginal probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole 150 mg + 1 globule of fenticonazole 600 mg on the same day; however, 10 applications of probiotics (<i>Lactobacillus acidophilus</i> ,<i>Lactobacillus rhamnosus</i> ,<i>Streptococcus thermophilus and Lactobacillus delbrueckii</i> subsp. Bulgaricus) were also administered beginning the 5th day after azole treatment. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole: oral.</p> <p>Fenticonazole: vaginal</p> <p>Probiotics: vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Azole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole 150 mg + 1 globule of fenticonazole 600 mg on the same day.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole: oral</p> <p>Fenticonazole: vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QD from day 1 to day 7, then, 1 capsule of <i>Streptococcus faecalis</i> (each capsule contained 6 × 10<sup>7</sup> colony forming units), QD from day 8 to day 14. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QD from day 1 to day 7.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 14, and on day 8, 1 capsule of <i>Streptococcus faecalis</i> (each capsule contained 6 × 10<sup>7</sup> colony forming units), QD from day 8 to day 14. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 14.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QN + 1 capsule of <i>Lactobacillus delbrueckii</i> Subsp. Lactis DM8909 (each capsule contained 0.25 × 10<sup>6</sup> colony forming units), QD from day 1 to day 10. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QN from day 1 to day 10.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 150 mg + 2 capsules of <i>Lactobacillus rhamnosus</i> GR‐1 and <i>Lactobacillus reuteri</i> RC‐14 (each capsule contained 1 × 10<sup>9</sup> viable cells of both strains) for 28 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + placebo group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 150 mg + 2 oral capsules of placebo once daily (every morning) for 28 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + oral protexin group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 300 mg (2 × 150 mg) + 2 protexin capsules per day (after meals in the morning and evening) for 3 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + placebo group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 300 mg (2 × 150 mg) + 2 placebo capsules daily (after meals in the morning and evening) for 3 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4 + 1 capsule of <i>Lactobacillus delbrueckii s</i>ubsp. Lactis DM8909 (each capsule contained 0.25 × 106 colony forming units), QD from day 1 to day 10. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 7, and then, 1 capsule of <i>Lactobacillus delbrueckii s</i>ubsp. Lactis DM8909 (each capsule contained 0.25 × 106 colony forming units), QD from day 8 to day 17. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 7.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>QD: every day; QN: every night.</p> </div> </div> </section> <section id="CD010496-sec-0083"> <h5 class="title">Comparison</h5> <p>Four trials compared vaginal suppository or tablet of clotrimazole plus vaginal capsules of probiotics with vaginal suppository or tablet of clotrimazole alone (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), three trials compared vaginal suppository of miconazole plus vaginal capsules of probiotics with vaginal suppository of miconazole alone (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>), two trials compared oral fluconazole plus oral capsules of probiotics with oral fluconazole plus oral capsules of placebo (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>), and one trial compared oral fluconazole and vaginal globule of fenticonazole plus oral capsules of probiotics with oral fluconazole and vaginal globule of fenticonazole (<a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). </p> </section> <section id="CD010496-sec-0084"> <h5 class="title">Outcomes</h5> <p>All the included trials reported at least one prespecified primary outcome of this review. Five trials reported short‐term clinical cure rate (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>), and only one trial reported long‐term clinical cure rate (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>). Seven trials reported short‐term mycological cure rate (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>), and three trials reported short‐term mycological cure rate (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). Three trials reported the first relapse after treatment (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>). Two trials reported the rate of serious adverse events (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>). Seven trials reported the rate of non‐serious adverse events (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). We did not obtain any data on the secondary outcomes: time to first relapse, need for any additional treatment at the end of the therapy, patient satisfaction with treatment and cost effectiveness. </p> </section> </section> <section id="CD010496-sec-0085"> <h4 class="title">Excluded studies</h4> <p>Sixteen trials were initially identified as potentially eligible for inclusion but were subsequently found to be ineligible. The main reason was that they were not RCTs (<a href="./references#CD010496-bbs2-0018" title="OzkinayE , TerekMC , YayciM , KaiserR , GrobP , TuncayG . The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG2005;112(2):234‐40. ">Ozkinay 2005</a>; <a href="./references#CD010496-bbs2-0024" title="YangLQ . Ding Jun Sheng used in the inhibition of vaginal yeast infection recurrence. Hainan Medical Journal2005;16(10):102. ">Yang 2005</a>; <a href="./references#CD010496-bbs2-0025" title="ZhangJ , YingP . Effect observation of Ding Jun Sheng to treat colpitis mycotica. Modern Journal of Integrated Traditional Chinese and Western Medicine2006;15(2):144‐5. ">Zhang 2006</a>; <a href="./references#CD010496-bbs2-0015" title="LiM , HuLQ , YangJZ . Clinical observation of Daktarin vaginal suppository and (or) Ding Jun Sheng to treat vulvovaginal candidiasis. Journal of Gannan Medical College2007;27(4):606‐7. ">Li 2007</a>; <a href="./references#CD010496-bbs2-0016" title="LiuJF , ZuoZH , SongL , ZhangJQ , WangJL . Clinical observation of Lactobacillus preparation for vulvovaginal candidiasis. Maternal and Child Health Care of China2008;23:4644‐6. ">Liu 2008</a>; <a href="./references#CD010496-bbs2-0019" title="PatelY , GopalanS , BaggaR , SharmaM , ChopraS , SethiS . A randomized trial comparing a polyherbal pessary (a complementary and alternative medicine) with Ginlac‐V pessary (containing clotrimazole, tinidazole and lactobacilli) for treatment of women with symptomatic vaginal discharge. Archives of Gynecology and Obstetrics2008;278(4):341‐7. ">Patel 2008</a>; <a href="./references#CD010496-bbs2-0011" title="AnukamKC , DuruMU , EzeCC , EgharevbaJ , AiyebelehinA , BruceA , et al. Oral use of probiotics as an adjunctive therapy to fluconazole in the treatment of yeast vaginitis: a study of Nigerian women in an outdoor clinic. Microbial Ecology in Health and Disease2009;21(2):72‐77. ">Anukam 2009</a>; <a href="./references#CD010496-bbs2-0013" title="FuJH . Effect observation of two treatment methods for vulvovaginal candidiasis. Contemporary Medicine2009;15(32):95. ">Fu 2009</a>; <a href="./references#CD010496-bbs2-0012" title="EhrstromS , DaroczyK , RylanderE , SamuelssonC , JohannessonU , AnzenB , et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes and Infection2010;12(10):691‐9. ">Ehrstrom 2010</a>; <a href="./references#CD010496-bbs2-0022" title="WangLP . The treatment and prevention of recurrence of vulvovaginal candidiasis. Strait Journal of Preventive Medicine2010;16(1):89‐90. ">Wang 2010</a>; <a href="./references#CD010496-bbs2-0021" title="SongLP . Effect of fluconazole combined Lactobacillus in treatment of vulvovaginal candidiasis. Journal of Modern Clinical Medicine2011;37(3):181‐2. ">Song 2011</a>; <a href="./references#CD010496-bbs2-0014" title="FuYJ . Effect observation of Ding Jun Sheng plus clotrimazole to treat Candida vaginitis. Journal of Henan Medical College for Staff and Workers2012;24(6):760‐1. ">Fu 2012</a>; <a href="./references#CD010496-bbs2-0020" title="ShiHC . The clinical effect of live preparation of Lactobacillus in treatment of vulvovaginal candidiasis and the recurrence rate. Chinese Journal of Microecology2012;24(3):278‐80. ">Shi 2012</a>; <a href="./references#CD010496-bbs2-0017" title="NagornayaVF , BayloNV . Pathogenetic treatment of candidal vulvovaginitis. China Journal of Modern Medicine2013;23(2):21‐4. ">Nagornaya 2013</a>; <a href="./references#CD010496-bbs2-0023" title="WuHY , HuMC , QuHM , SunLH . Lactasin capsules for postpartum vaginitis. Chinese Journal of New Drugs2013;22(7):819‐21. ">Wu 2013</a>; <a href="./references#CD010496-bbs2-0027" title="SigridovI , IvanovS , BatashkiI . Preliminary results of Lacofem trial ‐ first impressions. Akusherstvo i Ginekologiia2007;46 Suppl 2:29‐32. ">Sigridov 2007</a>). The reasons for exclusions are listed in the <a href="./references#CD010496-sec-0144" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD010496-sec-0086"> <h3 class="title">Risk of bias in included studies</h3> <p>We have summarized the 'Risk of bias' assessment in <a href="#CD010496-fig-0002">Figure 2</a> and <a href="#CD010496-fig-0003">Figure 3</a>. In addition, we provided additional details of the included trials in the 'Risk of bias' tables of the <a href="./references#CD010496-sec-0143" title="">Characteristics of included studies'</a> table. </p> <div class="figure" id="CD010496-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD010496-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010496-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD010496-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010496-sec-0087"> <h4 class="title">Allocation</h4> <section id="CD010496-sec-0088"> <h5 class="title">Random sequence generation (checking for possible selection bias)</h5> <p>Eight studies adequately reported the random sequence generation method by using a Research Randomizer software or a random draw method (All participants were numbered on an individual piece of paper, then took the paper (relevant to participant) out of a container randomly, without being able to see what was written on it; we judged this as a valid method after contacting the original authors.) making selection bias at entry unlikely (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). The remaining two studies did not report the random sequence generation methods, making the risk of selection bias at entry unclear (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> </section> <section id="CD010496-sec-0089"> <h5 class="title">Allocation concealment (checking for possible selection bias)</h5> <p>Two studies had adequate allocation concealment by using codified opaque‐sealed envelopes, and the risk of selection bias related to allocation concealment was low (<a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>). Six studies had a high selection bias as they did not conceal the allocation (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). Two studies had no description regarding concealment allocation disclosed; they were judged with unclear risk of bias for allocation concealment (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> </section> </section> <section id="CD010496-sec-0090"> <h4 class="title">Blinding</h4> <section id="CD010496-sec-0091"> <h5 class="title">Performance bias</h5> <p>Two studies used double blinding and a placebo‐controlled method; the participants and investigators were blind to the interventions, making performance bias unlikely (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). Six studies were at high performance bias as no blinding was adopted, as the judgment of symptoms and signs were subjectively evaluated; however, in these studies, both participants and investigators knew the allocated interventions during the study and outcomes may be influenced (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). Two studies used single blinding to the investigators, no blinding to participants as lacked a placebo control, and judgment of symptoms and signs by participants may have been influenced, so we also judged the two studies as having high risk of performance bias (<a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>). </p> </section> <section id="CD010496-sec-0092"> <h5 class="title">Detection bias</h5> <p>Risk of detection bias was low in two studies as the outcome assessors were blinded adequately (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). Six studies had a high detection bias as no blinding was adopted and the judgment of symptoms and signs outcomes by participants may be influenced (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). In two studies, although the outcome assessors were blinded, they still may have been influenced by participants as there was no blinding to participants, so the two studies were judged at high risk of detection bias (<a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>). </p> </section> </section> <section id="CD010496-sec-0093"> <h4 class="title">Incomplete outcome data</h4> <p>Five studies reported no withdrawals, but these trial did not have enough information for us to judge "yes" or "no" in intention‐to‐treat analyses and as a consequence, we assessed them as at unclear risk of attrition bias (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>). <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a> reported a withdrawal rate of 2.1% (less than 20%) during the treatment, <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a> reported a withdrawal rate of 4.6% (less than 20%) after the treatment, <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a> reported a withdrawal rate of 6.1% (less than 20%) after the treatment and <a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a> reported a withdrawal rate of 6.5% during the treatment and 7% after the treatment (less than 20%). The results of the four studies were not analyzed on an intention‐to‐treat basis, so we assessed them as at high risk of attrition bias. As <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a> reported no attrition or exclusion, we assessed it at low risk of attrition bias. </p> </section> <section id="CD010496-sec-0094"> <h4 class="title">Selective reporting</h4> <p>We found only one study reporting all the expected outcomes mentioned in their trial protocol (protocols number IRCT201106206807N3); it was clear that the published reports include all prespecified outcomes, so we judged it at low risk of selective reporting bias (<a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> <p>For the other nine studies, the trial protocols were not available and it was unclear if the published reports included all the expected outcomes, including those that were prespecified. The reports had insufficient information to permit judgment of "yes" or "no," so we rated them at unclear risk of bias. </p> </section> <section id="CD010496-sec-0095"> <h4 class="title">Other potential sources of bias</h4> <p>One study did not mention available data of the baseline characteristics between the two groups to judge the balance, we judged the study as having unclear risk of bias (<a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). Although authors of five included studies mentioned there were no significant differences in baseline characteristics, they provided no detailed data; therefore, we judged these studies at unclear risk of bias (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>). One study mentioned that one author held some patents associated with lactobacilli; however, his input was in protocol design, logistics, student supervision and assistance with the manuscript not in the accumulation of data. In addition, the author was blinded to the results until after the code was broken and findings acquired. We judged that probably this author had a conflict of interest that did not affect the quality of the evidence and there was low risk of bias in this study (<a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>). The remaining studies appeared to be free of other sources of bias (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> </section> </section> <section id="CD010496-sec-0096"> <h3 class="title" id="CD010496-sec-0096">Effects of interventions</h3> <p>See: <a href="./full#CD010496-tbl-0001"><b>Summary of findings for the main comparison</b> Probiotics used as adjuvants to conventional antifungal drugs compared with conventional antifungal drugs for the treatment of vulvovaginal candidiasis in non‐pregnant women</a> </p> <section id="CD010496-sec-0097"> <h4 class="title">1. Probiotics used alone versus conventional antifungal drugs</h4> <p>None of the included trials analyzed probiotics used alone compared with conventional antifungal drugs. </p> </section> <section id="CD010496-sec-0098"> <h4 class="title">2. Probiotics used as adjuvants to conventional antifungal drugs (before, during or after antifungal treatment) versus conventional antifungal drugs </h4> <p>All 10 included trials compared probiotics used as adjuvants to conventional antifungal drugs (before, during or after antifungal treatment) with conventional antifungal drugs (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). Data were available on 1656 outpatients with VVC, they were all non‐pregnant and without RVVC, diabetes mellitus, immunosuppressive disorders, taking immunosuppressant medication or evidence of co‐infection with other vulvovaginal infections. </p> <section id="CD010496-sec-0099"> <h5 class="title">Primary outcomes</h5> <section id="CD010496-sec-0100"> <h6 class="title">Clinical cure rate: short‐term (zero to 14 days after treatment)</h6> <p>Five trials evaluated 695 participants for short‐term clinical cure rate (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> <p>In the probiotics used as adjuvants to conventional antifungal drugs group, clinical cure occurred in 286/347 participants. In the conventional antifungal drugs group, a clinical cure occurred in 251/348 participants. Probiotics as adjuvants therapy was associated with a significantly improved on short‐term clinical cure rate when compared to conventional antifungal drugs alone (combined RR 1.14, 95% CI 1.05 to 1.24; 5 trials, 695 participants, I<sup>2</sup> = 28%; <a href="./references#CD010496-fig-0011" title="">Analysis 1.1</a>; <a href="#CD010496-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD010496-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.1 Clinical cure rate (short‐term)." data-id="CD010496-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.1 Clinical cure rate (short‐term). </p> </div> </div> </div> <p>A sensitivity analysis excluding the four studies at high risk of bias (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>, <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>, <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>, <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), only included <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>; however, the rate of short‐term clinical cure was still significantly increased in the probiotics used as adjuvants group compared to the conventional antifungal drugs alone group (RR 1.41, 95% CI 1.07 to 1.84; 1 trial, 90 participants; <a href="./references#CD010496-fig-0012" title="">Analysis 1.2</a>). </p> <p>The GRADE quality of the evidence for this outcome was low due to the limitations of risk of bias (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> <section id="CD010496-sec-0101"> <h6 class="title">Clinical cure rate: long‐term (one month after treatment)</h6> <p>Only one trial reported the long‐term clinical cure rate at one month after treatment (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>). There was no significant improvement associated with probiotics as adjuvant therapy on long‐term clinical cure rate at one month after treatment compared to conventional antifungal drugs alone (RR 1.07, 95% CI 0.86 to 1.33; 1 trial, 172 participants; <a href="./references#CD010496-fig-0014" title="">Analysis 1.4</a>). </p> <p>The quality of the evidence for this outcome was very low due to the limitations of risk of bias and imprecision (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> <section id="CD010496-sec-0102"> <h6 class="title">Clinical cure rate: long‐term (three months after treatment)</h6> <p>One trial reported long‐term clinical cure rate at three months after treatment (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>). There was no significant improvement associated with probiotics as adjuvant therapy on long‐term clinical cure rate at three months after treatment compared to conventional antifungal drugs alone (RR 1.30, 95% CI 1.00 to 1.70; 1 trial, 172 participants; <a href="./references#CD010496-fig-0015" title="">Analysis 1.5</a>). </p> <p>The quality of the evidence for this outcome was very low due to the limitations of risk of bias and imprecision (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> <section id="CD010496-sec-0103"> <h6 class="title">Mycological cure rate: short‐term (zero to 14 days after treatment)</h6> <p>Seven trials with 969 participants evaluated short‐term mycological cure rate (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> <p>In the probiotics used as adjuvants to conventional antifungal drugs group, mycological cure occurred in 452/485 participants. In the conventional antifungal drugs group, mycological cure occurred in 426/484 participants. Probiotics as adjuvants therapy was associated with a significantly improved short‐term mycological cure rate compared conventional antifungal drugs alone (RR 1.06, 95% CI 1.02 to 1.10; 7 trials, 969 participants, I<sup>2</sup> = 0%; <a href="./references#CD010496-fig-0016" title="">Analysis 1.6</a>; <a href="#CD010496-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD010496-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.6 Mycological cure rate (short‐term)." data-id="CD010496-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.6 Mycological cure rate (short‐term). </p> </div> </div> </div> <p>A sensitivity analysis excluding the six trials at high risk of bias (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>), only included <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>; it found the rate of short‐term mycological cure was no longer significantly difference between the groups (RR 1.14, 95% CI 0.97 to 1.33; 1 trial, 90 participants; <a href="./references#CD010496-fig-0017" title="">Analysis 1.7</a>). The result of this sensitivity analysis must be treated and interpreted carefully because of the small sample in <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>. </p> <p>The quality of the evidence for this outcome was low due to the limitations of risk of bias (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> <section id="CD010496-sec-0104"> <h6 class="title">Mycological cure rate: long‐term (one month after treatment)</h6> <p>Three trials with 627 participants evaluated long‐term mycological cure rate at one month after treatment (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>). </p> <p>In the probiotics used as adjuvants to conventional antifungal drugs group, mycological cure occurred in 294/314 participants. In the conventional antifungal drugs group, mycological cure occurred in 221/313 participants. Probiotics as adjuvants therapy was associated with no significant improvement on long‐term mycological cure rate at one month after treatment when compared to conventional antifungal drugs alone (RR 1.26, 95% CI 0.93 to 1.71; 3 trials, 627 participants, I<sup>2</sup> = 93%; <a href="./references#CD010496-fig-0020" title="">Analysis 1.10</a>; <a href="#CD010496-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD010496-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.10 Mycological cure rate (long‐term/1 month after treatment)." data-id="CD010496-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.10 Mycological cure rate (long‐term/1 month after treatment). </p> </div> </div> </div> <p>A sensitivity analysis excluding two trials at high risk of bias (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a>), only included <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; however, the rate of long‐term mycological cure rate at one month after treatment was still not significantly difference between probiotics used as adjuvants and conventional antifungal drugs alone (RR 1.32, 95% CI 0.99 to 1.77; 1 trial, 90 participants; <a href="./references#CD010496-fig-0021" title="">Analysis 1.11</a>). This result must be treated and interpreted carefully because of the small sample. </p> <p>The quality of the evidence for this outcome was very low due to the limitations of risk of bias, imprecision and inconsistency (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> <section id="CD010496-sec-0105"> <h6 class="title">Mycological cure rate: long‐term (three months after treatment)</h6> <p>Only one trial with 172 participants reported long‐term mycological cure rate at three months after treatment (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>). There was no statistically significant difference between probiotics used as adjuvants and conventional antifungal drugs alone in the rate of long‐term mycological cure at three months after treatment (RR 1.16, 95% CI 1.00 to 1.35; 1 trial, 172 participants; <a href="./references#CD010496-fig-0022" title="">Analysis 1.12</a>). </p> <p>The quality of the evidence for this outcome was very low due to the limitations of risk of bias and imprecision (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> <section id="CD010496-sec-0106"> <h6 class="title">Relapse rate</h6> <p>Three trials with 388 participants evaluated first relapse after treatment (<a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>). In the probiotics used as adjuvants to conventional antifungal drugs group, relapse occurred in 10/202 participants. In the conventional antifungal drugs group, relapse occurred in 27/186 participants. Probiotic use significantly decreased relapse rate at one month (RR 0.34, 95% CI 0.17 to 0.68; 3 trials, 388 participants, I<sup>2</sup> = 0%; <a href="./references#CD010496-fig-0023" title="">Analysis 1.13</a>; <a href="#CD010496-fig-0007">Figure 7</a>). No sensitivity analysis or subgroup analyses was done from the available trials. </p> <div class="figure" id="CD010496-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.13 Relapse rate." data-id="CD010496-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.13 Relapse rate. </p> </div> </div> </div> <p>The quality of the evidence for this outcome was very low due to the limitations of risk of bias and imprecision (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> <section id="CD010496-sec-0107"> <h6 class="title">Rate of serious adverse events</h6> <p>Two trials with 440 participants evaluated rate of serious adverse events (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>). The reported adverse events included severe vaginal burning, stinging or rash after the first use of miconazole nitrate vaginal suppository. There was no statistically significant difference between probiotics used as adjuvants and conventional antifungal drugs alone in the rate of serious adverse events (RR 0.80, 95% CI 0.22 to 2.94; 2 trials, 440 participants, I<sup>2</sup> = 0%; <a href="./references#CD010496-fig-0024" title="">Analysis 1.14</a>). No other serious adverse events were reported. </p> <p>The quality of the evidence for this outcome was low due to the limitations of risk of bias and imprecision (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a> for details). </p> </section> </section> <section id="CD010496-sec-0108"> <h5 class="title">Secondary outcomes</h5> <section id="CD010496-sec-0109"> <h6 class="title">Time to first relapse</h6> <p>We found no eligible RCTs reporting time to first relapse.</p> </section> <section id="CD010496-sec-0110"> <h6 class="title">Rate of non‐serious adverse events</h6> <p>Seven trials with 906 participants evaluated rate of non‐serious adverse events (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>; <a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a>; <a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a>; <a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a>; <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>; <a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a>; <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). </p> <p>The reported adverse events included mild vaginal dryness, burning, stinging, headache, loose stool and nausea. There was no statistically significant difference between probiotics used as adjuvants and conventional antifungal drugs alone in the rate of non‐serious adverse events (RR 0.90, 95% CI 0.48 to 1.70; 7 trials, 906 participants, I<sup>2</sup> = 0%; <a href="./references#CD010496-fig-0025" title="">Analysis 1.15</a>; <a href="#CD010496-fig-0008">Figure 8</a>). </p> <div class="figure" id="CD010496-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.14 Non‐serious adverse events." data-id="CD010496-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.14 Non‐serious adverse events. </p> </div> </div> </div> <p>The quality of the evidence for this outcome was low due to the limitations of risk of bias and imprecision (CIs were wide and included null effects). </p> </section> <section id="CD010496-sec-0111"> <h6 class="title">Need for any additional treatment at the end of the therapy</h6> <p>We found no eligible RCTs reporting need for any additional treatment at the end of the therapy. </p> </section> <section id="CD010496-sec-0112"> <h6 class="title">Patient satisfaction with treatment</h6> <p>We found no eligible RCTs reporting patient satisfaction with treatment.</p> </section> <section id="CD010496-sec-0113"> <h6 class="title">Cost effectiveness</h6> <p>We found no eligible RCTs reporting cost effectiveness.</p> </section> <section id="CD010496-sec-0114"> <h6 class="title">Subgroup analysis and investigation of heterogeneity</h6> <p>We performed subgroup analyses to explore the substantial heterogeneity we found in the analyses "Clinical cure rate: short‐term (zero to 14 days after treatment)." For this analysis, we explored whether differences in species of probiotics and route of administration (intravaginal administration of single species of probiotic or oral administration of multiple species of probiotics). Subgroups did not appear to be different (P = 0.10; <a href="./references#CD010496-fig-0013" title="">Analysis 1.3</a>; <a href="#CD010496-fig-0009">Figure 9</a>). The effect of the intervention for this outcome did not change according to these intervention characteristics. </p> <div class="figure" id="CD010496-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.3 Clinical cure rate (short‐term): subgroup analysis." data-id="CD010496-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.3 Clinical cure rate (short‐term): subgroup analysis. </p> </div> </div> </div> <p>In the analyses for "mycological cure rate: short‐term (zero to 14 days after treatment)," we explored whether differences in species of probiotics and route of administration (intravaginal administration of single species of probiotic or oral administration of multiple species of probiotics), subgroups did not appear to be different (P = 0.35; <a href="./references#CD010496-fig-0018" title="">Analysis 1.8</a>; <a href="#CD010496-fig-0010">Figure 10</a>). The effect of the intervention for this outcome did not change according to these intervention characteristics. </p> <div class="figure" id="CD010496-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.8 Mycological cure rate (short‐term): subgroup analysis." data-id="CD010496-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.8 Mycological cure rate (short‐term): subgroup analysis. </p> </div> </div> </div> <p>In addition, we explored the differences between different candidal strains (<i>Candida albicans</i> versus non‐albicans), and found that the subgroup estimates for the different candidal strains did not differ significantly in the oral administration of probiotics (P = 0.88; <a href="./references#CD010496-fig-0019" title="">Analysis 1.9</a>). </p> <p>In the analyses "mycological cure rate: long‐term (one month after treatment),", we explored the differences between routes of administration (intravaginal or oral administration), subgroups did not appear to be different (P = 0.80; <a href="./references#CD010496-fig-0020" title="">Analysis 1.10</a>). Subgroup analysis did not appear to explain the variability in the overall summary effect measures for the outcome long‐term mycological cure rate, so these findings should be interpreted with caution. </p> <p>We did not perform the subgroup analysis "age group of participants" because none of the included trials provided information. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010496-sec-0115" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010496-sec-0115">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010496-sec-0163">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010496-sec-0115"></div> <section id="CD010496-sec-0116"> <h3 class="title" id="CD010496-sec-0116">Summary of main results</h3> <p>Ten RCTs including 1656 participants fulfilled the inclusion criteria and were included. We judged the risk of bias for the included trials to be high. All the 10 included trials were in the comparison of "probiotics used as adjuvants to conventional antifungal drugs versus conventional antifungal drugs alone," and none of the retrieved studies compared "probiotic alone versus conventional treatment." </p> <p>We found the following results.</p> <p> <ul id="CD010496-list-0023"> <li> <p>Compared with conventional antifungal drugs alone, the addition of probiotics could enhance their effect in improving short‐term clinical cure rate (RR 1.14, 95% CI 1.05 to 1.24), regardless of the route of administration, and whether multiple species or single species of probiotics were used. The results did not seem to show a significant improvement between the two groups in long‐term clinical cure rate at one month after treatment (RR 1.07, 95% CI 0.86 to 1.33) and at three months after treatment (RR 1.30, 95% CI 1.00 to 1.70). </p> </li> <li> <p>Compared with conventional antifungal drugs alone, the addition of probiotics could enhance their effect in improving short‐term mycological cure rate (RR 1.06, 95% CI 1.02 to 1.10), but the addition of probiotics did not seem to be different to conventional antifungal drugs used alone in improving the long‐term mycological cure rate at one month after treatment (RR 1.26, 95% CI 0.93 to 1.71) and at three months after treatment (RR 1.16, 95% CI 1.00 to 1.35). </p> </li> <li> <p>Compared with conventional antifungal drugs alone, the addition of probiotics may reduce the first relapse rate at one month after treatment (RR 0.34, 95% CI 0.17 to 0.68). However, this result should be interpreted with caution because of the limitations related to the low quality of primary studies. </p> </li> <li> <p>There appears to be no difference between the addition of probiotics to conventional antifungal drugs and conventional antifungal drugs alone in the rate of serious adverse events (RR 0.80, 95% CI 0.22 to 2.94), the reported adverse events included severe vaginal burning, stinging or rash after the first use of miconazole nitrate vaginal suppository. </p> </li> <li> <p>There was no difference between the addition of probiotics to conventional antifungal drugs and conventional antifungal drugs alone in the rate of non‐serious adverse events (RR 0.90, 95% CI 0.48 to 1.70). The reported adverse events included mild vaginal dryness, burning, stinging, headache, loose stool and nausea. </p> </li> <li> <p>There was no available evidence for evaluating the time to first relapse, need for any additional treatment at the end of therapy, patient satisfaction with treatment and cost effectiveness. </p> </li> </ul> </p> <p>However, all the results found in this review should be interpreted with caution because of the limitations related to the low and very low quality of primary studies. </p> </section> <section id="CD010496-sec-0117"> <h3 class="title" id="CD010496-sec-0117">Overall completeness and applicability of evidence</h3> <p>Although we employed several methods to try to identify all RCTs and included both published and unpublished data in this review, this systematic review included trials at high risk of bias and consequently with very low to low confidence on the estimate of effect (see <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a>). We conducted sensitivity analyses or subgroup analyses (or both) that did not change the results of short‐term clinical cure rate, long‐term clinical cure rate and long‐term mycological cure rate. It strengthened the confidence that could be placed in these results, considering that most of the outcomes were very low or low quality evidence. This review was unable to report on the results of meta‐analysis of long‐term clinical cure rate (at one month and three months after treatment) and long‐term mycological cure rate (three months after treatment), as only one of the included studies offered the relevant data (<a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a>). This review was unable to address the issue of whether an oral administration of probiotics used as adjuvants to conventional antifungal drugs could improve the short‐term mycological cure rate, as only one study included with small sample offered the relevant data (<a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>). For the same reason, it was also unable to address the issue of whether the different candidal strains (<i>Candida albicans</i> versus non‐albicans) could influence the effectiveness of probiotics. For relapse rate, this review estimated the evidence only from studies that used the intravaginal probiotics. This review was also unable to address the issue of whether the different age group of women with VVC could influence the effectiveness of probiotics, because as of 2017, no RCT had focused on these topics. Likewise, none of the included studies assessed time to first relapse, need for any additional treatment at the end of therapy and patient satisfaction with treatment. Finally, this review could provide no evidence for assessing the effectiveness and safety of probiotics used alone versus conventional antifungal drugs, because none of the RCTs focused on these topics. </p> <p>This review included 10 studies that enrolled 1656 participants. These studies were conducted in China (seven studies), Brazil (one study), Bulgaria (one study) and Iran (one study), and were representative of a relatively wide range of racial, cultural and social groups. However, there was no study investigating the treatment of VVC in resource‐poor settings and this is a limitation to the general applicability of the results. This review focused on non‐pregnant women with VVC, and from the inclusion criteria, the results from this review could not be applied to pregnant women; women with RVVC, diabetes mellitus or immunosuppressive disorders; or women taking immunosuppressant medication. There was a small number of mild adverse events reported, and there were no other serious adverse events reported except severe vaginal burning, stinging or rash after the first use of miconazole nitrate vaginal suppository. It appears that probiotics could be considered safe in general from current limited data. </p> </section> <section id="CD010496-sec-0118"> <h3 class="title" id="CD010496-sec-0118">Quality of the evidence</h3> <p>We considered the 10 included trials to be at high risk of bias, and the confidence in the estimated effect in this review, assessed with the GRADE tool, ranged from very low to low (see <a href="#CD010496-fig-0002">Figure 2</a>, <a href="#CD010496-fig-0003">Figure 3</a>, and <a href="./full#CD010496-tbl-0001">summary of findings Table for the main comparison</a>). There is little confidence in the effect estimates, and the true effect is likely to be substantially different. The confidence is very low due to trial limitations (on risk of bias domain by sequence generation, allocation concealment and blinding of the included studies), inconsistency (substantial heterogeneity between studies and single study in some results) and imprecise results (outcome events with wide CIs, small sample size and few events). We could not evaluate publication bias, because there were too few included trials into each comparison. </p> </section> <section id="CD010496-sec-0119"> <h3 class="title" id="CD010496-sec-0119">Potential biases in the review process</h3> <p>In our review, reporting bias could not be assessed because of the limited numbers of studies for each outcome. Although we undertook several methods to try to identify all trials and included both published and unpublished data in this review, we could not exclude the possibility that studies with negative findings remain unpublished. There was substantial heterogeneity for some outcomes and our investigation of heterogeneity sources (which was based on a small number of trials for each comparison) could have limited value. In addition, the balance in baseline characteristics was not well explained and as confirmed by both published reports and contact authors, there may be unclear risk of bias for the results and conclusions. </p> </section> <section id="CD010496-sec-0120"> <h3 class="title" id="CD010496-sec-0120">Agreements and disagreements with other studies or reviews</h3> <p>We found one systematic review evaluating the effects of miconazole alone and miconazole plus a living preparation of <i>Lactobacillus</i> for the treatment of the uncomplicated VVC (<a href="./references#CD010496-bbs2-0034" title="CuiL , WangC , FuJ , XieLX , HuLN . Miconazole versus miconazole plus living preparation of Lactobacillus for vulvovaginal candidiasis: a systematic review. Chinese Journal of Evidence‐Based Medicine2010;10(1):89‐93. ">Cui 2010</a>). The authors included only trials using miconazole as the antifungal drug, and methodology details were unavailable. In contrast to our review, it concluded that currently available evidence showed that the effect in the combined group was better and the recurrence rate was lower. However, it did not report adverse events. Although <a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a>, which used an oral administration of probiotics, showed that probiotics used as adjuvants to conventional antifungal drugs performed better at improving the short‐term clinical cure rate, it showed no difference in short‐term mycological cure rate. Likewise, <a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a>, which also used an oral administration of probiotics, found no significant difference in long‐term mycological cure rate, but it showed a statistically significant difference in favor of probiotics used as adjuvants to conventional antifungal drugs in enhancing long‐term clinical improvement, which was determined as cure or persistence of <i>Candida</i> species and absence of symptoms. However, this result should be treated with caution as the small size was sample. <a href="./references#CD010496-bbs2-0012" title="EhrstromS , DaroczyK , RylanderE , SamuelssonC , JohannessonU , AnzenB , et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes and Infection2010;12(10):691‐9. ">Ehrstrom 2010</a> showed that adjunctive treatment of VVC with probiotics led to fewer recurrences and only a few adverse events (single episodes of headache and nausea), but had no impact on short‐term cure rate. However, the large and imbalanced rate of lost to follow‐up and the small sample could influence the result, and, as pointed out in the publication, probiotics were unavailable for women to use as an adjuvant to urogenital care in Nigeria, and even if probiotics were introduced, many of the population could not afford them. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010496-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram. RCT: randomized controlled trial." data-id="CD010496-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram. RCT: randomized controlled trial.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD010496-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD010496-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.1 Clinical cure rate (short‐term)." data-id="CD010496-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.1 Clinical cure rate (short‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.6 Mycological cure rate (short‐term)." data-id="CD010496-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.6 Mycological cure rate (short‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.10 Mycological cure rate (long‐term/1 month after treatment)." data-id="CD010496-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.10 Mycological cure rate (long‐term/1 month after treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.13 Relapse rate." data-id="CD010496-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.13 Relapse rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.14 Non‐serious adverse events." data-id="CD010496-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.14 Non‐serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.3 Clinical cure rate (short‐term): subgroup analysis." data-id="CD010496-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.3 Clinical cure rate (short‐term): subgroup analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.8 Mycological cure rate (short‐term): subgroup analysis." data-id="CD010496-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Probiotics + conventional antifungal drugs versus conventional antifungal drugs, outcome: 1.8 Mycological cure rate (short‐term): subgroup analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 1 Clinical cure rate (short‐term)." data-id="CD010496-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 1 Clinical cure rate (short‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 2 Clinical cure rate (short‐term): sensitivity analysis." data-id="CD010496-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 2 Clinical cure rate (short‐term): sensitivity analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 3 Clinical cure rate (short‐term): subgroup analysis." data-id="CD010496-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 3 Clinical cure rate (short‐term): subgroup analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 4 Clinical cure rate (long‐term/1 month after treatment)." data-id="CD010496-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 4 Clinical cure rate (long‐term/1 month after treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 5 Clinical cure rate (long‐term/3 months after treatment)." data-id="CD010496-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 5 Clinical cure rate (long‐term/3 months after treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 6 Mycological cure rate (short‐term)." data-id="CD010496-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 6 Mycological cure rate (short‐term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 7 Mycological cure rate (short‐term): sensitivity analysis." data-id="CD010496-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 7 Mycological cure rate (short‐term): sensitivity analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-08.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 8 Mycological cure rate (short‐term): subgroup analysis." data-id="CD010496-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 8 Mycological cure rate (short‐term): subgroup analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 9 Mycological non‐cure (short‐term/Candida albicans versus non‐albicans)." data-id="CD010496-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 9 Mycological non‐cure (short‐term/<i>Candida albicans</i> versus non‐albicans). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-10.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 10 Mycological cure rate (long‐term/1 month after treatment)." data-id="CD010496-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 10 Mycological cure rate (long‐term/1 month after treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 11 Mycological cure rate (long‐term/1 month after treatment): sensitivity analysis." data-id="CD010496-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 11 Mycological cure rate (long‐term/1 month after treatment): sensitivity analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 12 Mycological cure rate (long‐term/3 months after treatment)." data-id="CD010496-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 12 Mycological cure rate (long‐term/3 months after treatment). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-13.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 13 Relapse rate." data-id="CD010496-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 13 Relapse rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 14 Rate of serious adverse events." data-id="CD010496-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 14 Rate of serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010496-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/urn:x-wiley:14651858:media:CD010496:CD010496-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_t/tCD010496-CMP-001-15.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 15 Rate of non‐serious adverse events." data-id="CD010496-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Probiotics plus conventional antifungal drugs versus conventional antifungal drugs, Outcome 15 Rate of non‐serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/media/CDSR/CD010496/image_n/nCD010496-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010496-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Probiotics used as adjuvants to conventional antifungal drugs compared with conventional antifungal drugs for the treatment of vulvovaginal candidiasis in non‐pregnant women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Probiotics used as adjuvants to conventional antifungal drugs compared with conventional antifungal drugs for the treatment of vulvovaginal candidiasis in non‐pregnant women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Patient or population:</b> non‐pregnant women with vulvovaginal candidiasis </p> <p><b>Settings:</b> outpatient clinics in Brazil, Bulgaria, Iran and China </p> <p><b>Intervention:</b> probiotics used as adjuvants to conventional antifungal drugs </p> <p><b>Comparison:</b> conventional antifungal drugs </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="2" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Conventional antifungal drugs</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Probiotics used as adjuvants to conventional antifungal drugs</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Clinical cure rate (short‐term)</b> </p> <p>follow‐up: 5‐10 days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.14</b> (1.05 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>695<br/> (5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>721 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>822 per 1000</b> <br/> (757 to 894) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Clinical cure rate (long‐term)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>1 month after treatment</b> </p> <p>follow‐up: 1 month</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.07</b> (0.86 to 1.33) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>172<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>635 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>679 per 1000</b> <br/> (546 to 845) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>3 months after treatment</b> </p> <p>follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.30</b> (1.00 to 1.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>172<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>494 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>642 per 1000</b> <br/> (494 to 840) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Mycological cure rate (short‐term)</b> </p> <p>follow‐up: 5‐10 days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.06</b> (1.02 to 1.10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>969<br/> (7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See <sup>3</sup> in footnotes. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>880 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>933 per 1000</b> <br/> (898 to 968) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Mycological cure rate (long‐term)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>1 month after treatment</b> </p> <p>follow‐up: 28‐30 days</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> (0.93 to 1.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>627<br/> (3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See <sup>5</sup> in footnotes. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>706 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>890 per 1000</b> <br/> (657 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>3 months after treatment</b> </p> <p>follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b> (1.00 to 1.35) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>172<br/> (1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>741 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>860 per 1000</b> <br/> (741 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Relapse rate</b> </p> <p>follow‐up: 30‐37 days after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.34</b> (0.17 to 0.68) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>388<br/> (3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>1,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>145 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> <br/> (25 to 99) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="2" rowspan="2" valign="top"> <p><b>Rate of serious adverse events</b> </p> <p>follow‐up: 5‐90 days after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Medium risk population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.80</b> (0.22 to 2.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>440<br/> (2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (5 to 68) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels due to very serious risk of bias: the included studies had a high or unclear risk of bias in at least one key domain i.e. random sequence generation, allocation concealment or blinding. </p> <p><sup>2</sup>Downgraded one level due to serious imprecision: the 95% CI were wide and included null effects. </p> <p><sup>3</sup>A sensitivity analysis that excluded studies with high risk of bias and included only one study showed that the rate of short‐term mycological cure was changed to no significantly difference between two arms. For the heterogeneity and difference in results, we think the reasons may be associated with the small sample of included study, high risk of bias of studies that were excluded for sensitivity analysis. </p> <p><sup>4</sup>Downgraded one level due to inconsistency: there was a substantial heterogeneity between studies. </p> <p><sup>5</sup>There was heterogeneity that may be attributable to differences in route of the administration of probiotics, we undertook a subgroup analysis, the results showed no statistically significant difference between two arms in either subgroup. </p> <p><sup>6</sup>Downgraded one level due to serious imprecision: small sample size and few events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Probiotics used as adjuvants to conventional antifungal drugs compared with conventional antifungal drugs for the treatment of vulvovaginal candidiasis in non‐pregnant women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010496-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Species of Candida isolated from lower genital tract in women with vulvovaginal candidiasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Species </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Response to azoles</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida albicans</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80‐90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensitive</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida glabrata</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5‐10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida krusei</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida lusitaniae</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida parapsilosis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida pseudotropicalis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Candida tropicalis</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tends to be resistant</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Source: <a href="./references#CD010496-bbs2-0032" title="BieberEJ , SanfilippoJS , HorowitzIR . Clinical Gynecology. Philadelphia (PA): Churchill Livingstone, 2006. ">Bieber 2006</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Species of Candida isolated from lower genital tract in women with vulvovaginal candidiasis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010496-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">CDC recommended treatments for uncomplicated vulvovaginal candidiasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Non‐prescription intravaginal agents</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Prescription intravaginal agents</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Butoconazole 2% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Clotrimazole 1% cream 5 g intravaginally for 7‐14 days</p> <p>OR</p> <p>Clotrimazole 2% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Miconazole 2% cream 5 g intravaginally for 7 days</p> <p>OR</p> <p>Miconazole 4% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Miconazole 100 mg vaginal suppository, 1 suppository for 7 days</p> <p>OR</p> <p>Miconazole 200 mg vaginal suppository, 1 suppository for 3 days</p> <p>OR</p> <p>Miconazole 1200 mg vaginal suppository, 1 suppository for 1 day</p> <p>OR</p> <p>Tioconazole 6.5% ointment 5 g intravaginally in a single application</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Butoconazole 2% cream (single dose bioadhesive product), 5 g intravaginally for 1 day </p> <p>OR</p> <p>Nystatin 100,000 unit vaginal tablet, 1 tablet for 14 days</p> <p>OR</p> <p>Terconazole 0.4% cream 5 g intravaginally for 7 days</p> <p>OR</p> <p>Terconazole 0.8% cream 5 g intravaginally for 3 days</p> <p>OR</p> <p>Terconazole 80 mg vaginal suppository, 1 suppository for 3 days</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>CDC: Centers for Disease Control and Prevention.</p> <p>Source: <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">CDC recommended treatments for uncomplicated vulvovaginal candidiasis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010496-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">CDC recommended treatments for complicated vulvovaginal candidiasis</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Recurrent vulvovaginal candidiasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Initial regimen:</b> </p> <p>7‐14 days of any topical azole drug</p> <p>OR</p> <p>Fluconazole 100 mg, 150 mg or 200 mg orally once daily every 3rd day for a total of 3 doses (days 1, 4 and 7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maintenance regimen:</b> </p> <p>Fluconazole 100 mg, 150 mg or 200 mg orally once weekly for 6 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Severe vulvovaginal candidiasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Intravaginally once daily for 7 to 14 days of any topical azole drug</p> <p>OR</p> <p>Fluconazole 150 mg orally once daily in 2 doses (second dose 72 hours after initial dose) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Non‐albicans vulvovaginal candidiasis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Non‐fluconazole azole (oral or topical)</p> <p>7‐14 days</p> <p>OR</p> <p>Boric acid gelatin capsule</p> <p>Intravaginally once daily for 14 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Abnormal host</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>More prolonged (i.e. 7‐14 days) conventional antifungal drugs is necessary</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>CDC: Centers for Disease Control and Prevention.</p> <p>Source: <a href="./references#CD010496-bbs2-0033" title="Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. Journal of the Mississippi State Medical Association2015;56(12):372‐5. ">CDC 2015</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">CDC recommended treatments for complicated vulvovaginal candidiasis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010496-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Common microorganisms used as probiotics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><i><b>Lactobacillus</b> </i><b>species:</b> </p> <p><i>Lactobacillus acidophilus</i> </p> <p><i>Lactobacillus bulgaricus</i> </p> <p><i>Lactobacillus casei</i> </p> <p><i>Lactobacillus crispatus</i> </p> <p><i>Lactobacillus delbrueckii</i> </p> <p><i>Lactobacillus fermentum</i> </p> <p><i>Lactobacillus gasseri</i> </p> <p><i>Lactobacillus johnsonii</i> </p> <p><i>Lactobacillus lactis</i> </p> <p><i>Lactobacillus plantarum</i> </p> <p><i>Lactobacillus reuteri</i> </p> <p><i>Lactobacillus rhamnosus</i> GG </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Streptococcus</b> </i><b>species:</b> </p> <p>S<i>treptococcus thermophilus</i> </p> <p> </p> <p> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Yeast:</b> </p> <p><i>Saccharomyces boulardii</i> </p> <p> </p> <p> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Other species:</b> </p> <p><i>Bacillus cereus</i> </p> <p><i>Enterococcus faecalisa</i> </p> <p><i>Enterococcus faeciuma</i> </p> <p><i>Escherichia coli</i> Nissle </p> <p> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Bifidobacterium</b> </i><b>species:</b> </p> <p><i>Bifidobacterium adolescentis</i> </p> <p><i>Bifidobacterium animalis</i> </p> <p><i>Bifidobacterium bifidum</i> </p> <p><i>Bifidobacterium breve</i> </p> <p><i>Bifidobacterium infantis</i> </p> <p><i>Bifidobacterium lactis</i> </p> <p><i>Bifidobacterium longum</i> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>Sources: <a href="./references#CD010496-bbs2-0079" title="SenokAC ,  IsmaeelAY ,  BottaGA . Probiotics: facts and myths. Clinical Microbiology and Infection2005;11(12):958‐66. ">Senok 2005</a>; <a href="./references#CD010496-bbs2-0035" title="DoronS ,  GorbachSL . Probiotics: their role in the treatment and prevention of disease. Expert Review of Anti‐Infective Therapy2006;4(2):261‐75. ">Doron 2006</a>; <a href="./references#CD010496-bbs2-0077" title="SantosaS ,  FarnworthE ,  JonesPJ . Probiotics and their potential health claims. Nutrition Reviews2006;64(6):265‐74. ">Santosa 2006</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Common microorganisms used as probiotics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010496-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Brief summary of interventions in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Included study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intervention groups</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intervention doses and duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intervention administration route</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0001" title="HanYX , ZhaoSW . Clinical observation of Ding Jun Sheng and clotrimazole vaginal tablet in the treatment of vulvovaginal candidiasis. Anhui Medical Journal2006;27(6):528‐9. ">Han 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4 + 1 capsule of <i>Lactobacillus delbrueckii</i> Subsp. Lactis DM8909 (each capsule contained 0.25 × 10<sup>6</sup> colony forming units), QD from day 1 to day 10. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0002" title="HuaY , LinM , WangLD , XiaL . Observation of curative effect of miconazole and lactobacillus on vulvovaginal candidiasis treated. Chinese Journal of Microecology2008;20(4):386‐7. ">Hua 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 400 mg, QD from day 1 to day 6, and then 1 capsule of <i>Lactobacillus delbrueckii s</i>ubsp. Lactis DM8909 (each capsule contained 0.25 × 10<sup>6</sup> colony forming units), QD from day 7 to day 16. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 vaginal suppository of Miconazole nitrate (400 mg), QD from day 1 to day 6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0003" title="KovachevSM , Vatcheva‐DobrevskaRS . Local probiotic therapy for vaginal Candida albicans infections. Probiotics and Antimicrobial Proteins2015;7(1):38‐44. ">Kovachev 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Azole + vaginal probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole 150 mg + 1 globule of fenticonazole 600 mg on the same day; however, 10 applications of probiotics (<i>Lactobacillus acidophilus</i> ,<i>Lactobacillus rhamnosus</i> ,<i>Streptococcus thermophilus and Lactobacillus delbrueckii</i> subsp. Bulgaricus) were also administered beginning the 5th day after azole treatment. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole: oral.</p> <p>Fenticonazole: vaginal</p> <p>Probiotics: vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Azole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole 150 mg + 1 globule of fenticonazole 600 mg on the same day.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole: oral</p> <p>Fenticonazole: vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0004" title="LinH , MengXB . Clinical application of Lactasin capsules in vaginitis. Journal of Practical Medicine2006;22(16):1927‐8. ">Lin 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QD from day 1 to day 7, then, 1 capsule of <i>Streptococcus faecalis</i> (each capsule contained 6 × 10<sup>7</sup> colony forming units), QD from day 8 to day 14. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QD from day 1 to day 7.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0005" title="MaL , LiL . Miconazole plus Lactasin capsules to treat vulvovaginal candidiasis (54 cases). Herald of Medicine2007;26(9):1041‐2. ">Ma 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 14, and on day 8, 1 capsule of <i>Streptococcus faecalis</i> (each capsule contained 6 × 10<sup>7</sup> colony forming units), QD from day 8 to day 14. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 14.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0006" title="MaiXY . Analysis of probiotic lactobacillus's effect on vulvovaginal candidiasis. Chinese Journal of Microecology2007;19(4):362‐3. ">Mai 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QN + 1 capsule of <i>Lactobacillus delbrueckii</i> Subsp. Lactis DM8909 (each capsule contained 0.25 × 10<sup>6</sup> colony forming units), QD from day 1 to day 10. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of clotrimazole 150 mg, QN from day 1 to day 10.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0007" title="MartinezRC , FranceschiniSA , PattaMC , QuintanaSM , CandidoRC , FerreiraJC , et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14. Letters in Applied Microbiology2009;48(3):269‐74. ">Martinez 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 150 mg + 2 capsules of <i>Lactobacillus rhamnosus</i> GR‐1 and <i>Lactobacillus reuteri</i> RC‐14 (each capsule contained 1 × 10<sup>9</sup> viable cells of both strains) for 28 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + placebo group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 150 mg + 2 oral capsules of placebo once daily (every morning) for 28 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0008" title="NouraeiS , Amir Ali AkbariS , JorjaniM , Alavi MajdH , AfrakhtehM , Ghafoorian , A , et al. Comparison between fluconazole with oral protexin combination and fluconazole in the treatment of vulvovaginal candidiasis. ISRN Obstetrics and Gynecology2012;2012:375806. ">Nouraei 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + oral protexin group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 300 mg (2 × 150 mg) + 2 protexin capsules per day (after meals in the morning and evening) for 3 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fluconazole + placebo group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 dose of fluconazole 300 mg (2 × 150 mg) + 2 placebo capsules daily (after meals in the morning and evening) for 3 days. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0009" title="YangQ , ZhaoWF , ZhengJP . Clinical observation of mycobacterium lacticola preparation in treatment of vaginal vini candidiasis using clotrimazole effervescent tablets. Chinese Journal of Hospital Pharmacy2009;29(16):1377‐9. ">Yang 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4 + 1 capsule of <i>Lactobacillus delbrueckii s</i>ubsp. Lactis DM8909 (each capsule contained 0.25 × 106 colony forming units), QD from day 1 to day 10. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clotrimazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of clotrimazole 500 mg on day 1 and day 4.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD010496-bbs2-0010" title="ZhangCX , GaoYT , GaoHL . Preventive effect of probiotic Lactobacillus on vulvovaginal candidiasis. Maternal and Child Health Care of China2005;20(17):2239‐40. ">Zhang 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole + probiotic group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 7, and then, 1 capsule of <i>Lactobacillus delbrueckii s</i>ubsp. Lactis DM8909 (each capsule contained 0.25 × 106 colony forming units), QD from day 8 to day 17. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miconazole group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 suppository of miconazole nitrate 200 mg, QD from day 1 to day 7.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>QD: every day; QN: every night.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Brief summary of interventions in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/full#CD010496-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010496-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Probiotics plus conventional antifungal drugs versus conventional antifungal drugs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rate (short‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [1.05, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rate (short‐term): sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.07, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical cure rate (short‐term): subgroup analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [1.05, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Intravaginal administration and single species of probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>605</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [1.02, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Oral administration and multiple species of probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.07, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical cure rate (long‐term/1 month after treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.86, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Clinical cure rate (long‐term/3 months after treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [1.00, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mycological cure rate (short‐term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [1.02, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mycological cure rate (short‐term): sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.97, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mycological cure rate (short‐term): subgroup analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>969</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [1.02, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Intravaginal administration and single species of probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>879</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [1.01, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Oral administration and multiple species of probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.97, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mycological non‐cure (short‐term/<i>Candida albicans</i> versus non‐albicans) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.16, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Candida albicans </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.09, 2.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Non‐albicans</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.11, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mycological cure rate (long‐term/1 month after treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.93, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Intravaginal administration of probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>588</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.83, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 oral administration of probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.99, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mycological cure rate (long‐term/1 month after treatment): sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.99, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mycological cure rate (long‐term/3 months after treatment) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.00, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Relapse rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.17, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Rate of serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.22, 2.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Rate of non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>906</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.48, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Probiotics plus conventional antifungal drugs versus conventional antifungal drugs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010496.pub2/references#CD010496-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010496.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010496-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010496-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010496-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010496-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD010496-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD010496-note-0017">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD010496-note-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010496-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010496\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010496\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010496\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010496\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010496\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=23LRTUA6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010496.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010496.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010496.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010496.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010496.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717222217"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010496.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717222221"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010496.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db2a80a269365',t:'MTc0MDcxNzIyMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 